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ABSTRACT OF THE DISSERTATION
The Convergence of Metabolism and Virulence Factor Regulation on Streptococcus
pyogenes pathogenesis
by
Zachary Thomas Cusumano
Doctor of Philosophy in Biology and Biomedical Sciences (Biochemistry)
Washington University in St. Louis, 2012
Professor Michael G. Caparon, Chairperson

Nutrient acquisition is a strong driving force in the evolution of pathogenesis. For
many pathogens such as Streptococcus pyogenes, the coordination of metabolism with
the expression of virulence factors is necessary for colonization. Previous research
examining the regulation of virulence factors in S. pyogenes identified a unique catabolite
sensing regulatory pathway composed of the tagatose bis-phosphate aldolase LacD.1.
Examination of LacD.1 has determined that while it still maintains its ancestral
enzymatic activity its regulation occurs via a mechanism independent of catalysis. Our
approach to understanding how S. pyogenes’ metabolism contributes to pathogenesis
involves both understanding the adaptation of LacD.1 as a novel metabolic regulator as
well as investigating the role of LacD.1-regulated genes in pathogenesis.
Analysis of LacD.1’s ancestral enzymatic activity and comparison to a paralogous
protein encoded in the genome, LacD.2, suggested that the adaptation of LacD.1 required
a decrease in enzymatic activity as compared to LacD.2. This decrease in activity is
largely due to an increase in Km, and suggests an optimization in affinity for the signaling
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substrate(s) necessary for LacD.1’s regulation. Additionally the regulatory function of
LacD.1 was found to be essential for the fitness of bacteria when cultured in media that
mimicked a soft tissue environment. The selective advantage observed for bacteria in
this environment can likely be attributed to LacD.1’s positive regulation of the arc
operon, which encodes genes necessary for arginine catabolism and contributes to both
the production of ATP and protection from acid stress.
To further investigate the arc operon’s contribution to the fitness of bacteria in a
soft tissue environment we examined the influence of arginine catabolism on
pathogenesis. Analysis of several mutants defective in catabolism revealed that both the
utilization of arginine as well as the novel utilization of citrulline aids in S. pyogenes
pathogenesis. This influence on pathogenesis included contributions to both the cellular
metabolism of S. pyogenes as well as the modulation of the host immune response.
Taken together this work demonstrates that LacD.1’s adaptation to a regulator and its
coordination of metabolism and virulence factor expression was essential to increase the
fitness of S. pyogenes as a pathogen.
!
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CHAPTER I
Introduction

Streptococcus pyogenes and Streptococcal Diseases
Streptococcus pyogenes (group A streptococcus) is a strict human pathogen
believed to cause the widest range of diseases compared to any other bacterium (130).
This variety of diseases caused by S. pyogenes includes infection in a number of different
tissues through out the body (Figure 1(104)). While the clinical symptoms of these
diseases can vary greatly, they can loosely be classified into three main categories:
superficial, invasive, and post-streptococcal diseases.
!Superficial group A streptococcal infections
Superficial infections are the most common form of S. pyogenes infections and include
pharyngitis and pyoderma.
Pharyngitis often occurs in children
between the age of 5-12 years and
presents with fever, tender and
enlarged anterior cervical nodes
along with tonsillopharyngeal
erythema and exudate (42).
Although it is believed treatment
with antibiotics does not drastically reduce the duration of the infection they are
recommended in most cases(130).
Pyoderma refers to purulent skin infections and includes non-bullous impetigo typically
caused by S. pyogenes. Impetigo is common in children and is often found in more
tropical climates as well as developing countries. Infection usually follows an initial
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trauma, allowing introduction of the bacteria. Initial presentation usually occurs as a
small pimple or scratch that gradually evolves to a purulent lesion. These lesions tend to
be highly contagious thus spreading quickly to other regions of the body or to other
individuals in close proximity (48).
Diagnostic assays for these diseases often involve the culturing of the bacteria
from the site of infection, followed by observation of beta-hemolysis by streptococci on
sheep-blood agar plates. Additionally a rapid antigen test has been developed and is
believed to have a high degree of specificity and sensitivity (50). While there is a
growing rise of antibiotic resistance occurring in most pathogens, S. pyogenes remains
sensitive to penicillin, the first-line agent commonly recommended for treatment (12).
In 2005 it was estimated that there was 111 million existing cases of pyoderma and 616
million new cases of pharyngitis, demonstrating the frequency of these superficial, less
invasive diseases (21).
Invasive group A streptococcal infections
Despite the prevalence of superficial group A streptococcus infections there are still a
large number of invasive cases, 663,000, that result in nearly 170,000 deaths a year (21).
Invasive cases of S. pyogenes are described as infection of normally sterile sites and
include infections of soft tissue, pneumonia, and meningitis.
Necrotizing fasciitis is one of the most well known invasive diseases due to its
high morbidity and mortality, and involves infection of the muscle fascia and epidermis.
The severity of this infection is amplified by the rate at which disease progresses, with
90% of deaths in children occurring within 48 hrs after presentation (26, 76). Initial
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diagnosis requires detection of infection past the dermis and typically involves
disproportionate pain and tenderness around the site of infection. Once diagnosed
surgery and amputation are often required for survival.
In addition to necrotizing fasciitis other invasive diseases including pneumonia
and meningitis require aggressive treatments. Pneumonia accounts for 10% of invasive
S. pyogenes diseases, and often requires antibiotic treatment that can last for three weeks
or longer (96). Meningitis caused by S. pyogenes is fairly rare in the first world but still
occurs in developing countries today and is often lethal (125).
Additional complications of invasive streptococcal infections can arise as a result
of the large number of superantigens produced by S. pyogenes and can culminate in
streptococcal toxic shock syndrome. Superantigens are known to activate T-cells by
linking Class II molecules on antigen-presenting cells to the T-cell receptor. This nonspecific interaction results in a much larger stimulation of T-cells and the production of a
large amounts of cytokines (80, 109). This “cytokine storm” results in a fever, rash, and
hypotension followed by shock and organ failure (132).
Post-streptococcal diseases
While post-streptococcal diseases are the least understood they account for the most
morbidity and mortality of all streptococcal infections, with 233,000 deaths caused by
rheumatic heart disease alone (21). Other post-streptococcal diseases include acute
rheumatic fever, acute glomerulonephritis, and reactive arthritis. Additionally other
immunopathologcial syndromes such as PANDAS (pediatric autoimmune
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neurophsychiatric disorders) have been identified as being associated with streptococcal
infections (37, 126).

Pathogenesis of Streptococcus pyogenes
Given the lack of any environmental reservoir, S. pyogenes has evolved a number of
strategies to allow for the efficient colonization of the skin and mucous membranes of
humans. Infection of colonization sites often occurs in the superficial tissue, and while
self-limiting can result in transmission of the bacteria followed by colonization of a new
host. This infection cycle of S. pyogenes requires a number of virulence factors that have
evolved specialized function within the human host (Figure 2 (140)).
Adhesion
The initial step in a S. pyogenes infection begins with attachment to a cell receptor
or surface structure. A proposed model of adherence suggests that attachment occurs by
a two-step mechanism (34, 58). The
first step involves the binding of the
bacteria cell wall component,
lipoteichoic acid (LTA) to the host
protein fibronectin(5, 127). This initial
interaction is believed to be weak and
transient and serves to allow for a
second more specific interaction to
occur between an additional S.
pyogenes adhesin and a host ligand. These additional adhesins provide tissue specificity
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and increased adherence, and include the hyaluronic acid capsule, M protein, and Protein
F.
The hyaluronic acid capsule of S. pyogenes is composed of repeating units of
glucuronic acid and N-acetylglcosamine(133) and is synthesized by the three S. pyogenes
genes hasA, hasB, and hasC that form a polycistronic transcript(41). Investigation into
an acapsular mutant demonstrated that capsule aids in adhesion by directly interacting
with host cells that express CD44 (38). However, an inverse correlation was
demonstrated with CD44 deficient cells, demonstrating an inhibition of binding to CD44
negative cells (35). In addition to playing a critical role in adhesion, capsule has also
been demonstrated to protect the bacteria from phagocytosis by host immune cells (148).
Probably the most studied virulence factor of S. pyogenes is M protein, a major
surface protein that is anchored in the membrane by the C-terminus and extends from the
cell wall surface. This protein forms a coiled-coil dimer and is composed of a conserved
domain located in the C-terminus, and a variable domain in the N-terminus (34, 37).
Previously the variable region of M-protein, encoded in the emm gene, had been used
diagnostically to classify S. pyogenes strains through serological typing. Recently this
serological classification has been replaced with sequence typing of the emm gene, and to
date over 200 emm types have been indentified (9). In addition to serving as a diagnostic
tool, it is believed that both domains of M-protein play key roles during an infection with
specific interactions with host cell structures. The variable domain has been
demonstrated to bind fibronectin, however given the location of this activity in the
variable region it has been determined to be dependent on the type of M protein
expressed (36, 118). Conversely the C-terminal region contains repeating units that have
!
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been shown to interact with the host receptor CD46 (100), and while it has not been
tested it is believed this interaction is conserved among all M-proteins. In addition to its
function as an adhesin, M-protein also prevents phagocytosis (119), contributing to its
role in colonization and pathogenesis (2, 33).
In addition to the adhesins described above, S. pyogenes relies on a number of
additional adhesins, including: protein F, protein F2, PFPB, Sfbx, and FBP54 to target
binding to host fibronectin. The targeting of fibronectin appears to occur not only in S.
pyogenes, but also through out nature, with a number of pathogens evolving mechanisms
to bind fibronectin (58). This convergence on a single target strongly suggests that
interactions with fibronectin play a key role in bacterial pathogenesis. Overall the variety
of adhesins expressed by S. pyogenes aids in its ability to colonize a number of different
tissues and cause disease through out the body.
Colonization
Following adherence, colonization of the skin or nasopharynx requires a number
of virulence factors that allow the bacteria to replicate while remaining protected from
the host immune system. This involves the coordinated expression of a number of
secreted bacterial proteins that function in eliciting host cell death, degradation of host
cytokines, and evasion of host defenses.
Streptolysin O & Streptococcus NAD Glycohydrolase
Two major virulence factors expressed by S. pyogenes include the cytolysin
Streptolysin O (SLO) and the NAD glycohydrolase (SPN). These two virulence factors
are encoded in the same operon, and are expressed as a single transcript. As a cytolysin,
!
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SLO is known to bind to host membranes and oligomerize to form large pores (11, 88).
This pore formation, serves multiple purposes including the induction of apoptosis in host
cells (14), as well as the translocation of SPN into the host cell (88). The translocation of
SPN has been demonstrated to be specific, suggesting a direct interaction between these
two proteins (53). Once inside the cell, the function of SPN is still unknown, but detailed
biochemical experiments have identified that it is a potent NAD glycohydrolase, which
upon entry into host cells results in increased cellular death (88) (52). Interestingly,
additional variants of SPN that lack this glycohydrolase activity have been identified, but
proven to be equally virulent (52), suggesting an additional role for SPN in the host cell.
Additionally, variants of SPN have also been shown to correlate with strains associated
with a specific tissue tropism (114); which may indicate the separate functions of these
two variants of SPN are required for infection of different tissues. Nevertheless, the
combination of SLO and SPN result in increased host epithelial and immune cell death
aiding in nutrient acquisition and protection from killing, respectively (54, 99).
Interleukin-8 protease (SpyCEP), C5a peptidase (ScpA), Streptolysin S (SagA)
S. pyogenes’ propensity to colonize and survive within the host stems from the
number of virulence factors produced that are dedicated to the evasion of host defenses.
This evasion is accomplished by several proteins that inactivate or block specific
chemokines that result in the recruitment of neutrophils. This includes the surface
peptidases SpyCEP and ScpA that inactivate IL-8 and C5a, respectively, inhibiting the
chemotaxis of neutrophils to the site of infection (43) (149). Disruption of either of these
virulence factors, results in an influx of neutrophils to the site of infection and ultimately
a decrease in bacterial survival (68, 151). Finally streptolysin S or sagA is a small,
!
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modified peptide that is secreted by S. pyogenes and aids in pathogenesis through a
number of different mechanisms. One of sagA’s most notable roles is as one of the two
toxins that result in the lysis of red blood cells that is used diagnostically to identify S.
pyogenes through !-hemolysis. In addition to the lysis of red blood cells, sagA is able to
help evade the host immune response through direct lysis of neutrophils (95) as well as
through inhibition of neutrophil recruitment to the site of an infection(78).
(IdeS) Immungolobulin G endopeptidase & Streptococcal inhibitor of complement (SIC)
In addition to inhibiting the recruitment of host immune cells, S. pyogenes has
also evolved a number of mechanisms to resist phagocytosis and killing. IdeS another
peptidase, can cleave IgG bound to the surface of S. pyogenes thus preventing Fcmediated opsonophagocytosis(77, 144). M protein described above is able to bind the
complement regulatory protein Factor H, thus inhibiting phagocytosis (65). Additionally,
protection of S. pyogenes from the host can occur through the secretion of a 31-kDa
protein, SIC. This protein is believed to protect the bacteria from the antimicrobial
peptides LL-37 and "-defensins produced by the host (45, 46, 49). All together these
virulence factors serve an essential role, allowing S. pyogenes to both evade and protect
itself from the host so that it may replicate and successfully colonize host tissue.
Dissemination
While S. pyogenes can be carried asymptomatically, with one meta-analysis
finding 12% of children examined colonized (120), typically colonization by group A
streptococcus results in an acute infection, transmission to a new host, followed by
clearance. Less frequently S. pyogenes can disseminate to deeper tissue causing severe,
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life-threatening diseases. While dissemination of S. pyogenes requires a number of
virulence factors, some discussed above, there are a select few that have been associated
with increased invasiveness and may be leading determinants.
Streptococcal exotoxin B (SpeB)
SpeB is a cysteine protease secreted by S. pyogenes as a 40 kDa zymogen that is
autocatalytically processed to the 28 kDa active form(59). This virulence factor is highly
conserved among strains of S. pyogenes (70), and is among the most abundant protein
secreted by most strains (51). While there are extensive studies demonstrating the ability
of speB to cleave a number of different host proteins, including but not limited to:
vitronectin, fibronectin (70), activating IL-1b precursor to the active form (69), activating
an endothelial cell matrix metalloprotease (18), and releasing kinins from their precursor
(60), the role of speB in invasive disease is still debated. A study looking at antibodies in
patients with streptococcal infections found that during invasive disease antibodies are
made against speB, with fatal cases associated with lower amounts of antibodies
compared to milder infections (63). Additionally, several studies have demonstrated a
major role of speB in pathogenesis in a number of different mouse and tissue models of
infection, suggesting a direct link between speB and virulence (67, 84-86). However in
contrast, recent studies have demonstrated that comparison of isolates from patients with
invasive disease versus pharyngeal disease have revealed a global shift in their
transcriptional profile due to a mutation in a two-component sensor kinase covS. This
mutation has resulted in the mis-regulation of a number of virulence factors including a
reduction in speB production in invasive isolates (134). In addition, to increasing the
transcripts of certain virulence factors, the down regulation of speB leads to an increase
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in stability of other secreted or surface associated virulence factors that are typically
degraded by speB’s protease activity (4). These two conflicting roles of speB in invasive
streptococcal infections underscores the complexity of S. pyogenes infections, and
suggests that invasive disease may involve the confluence of a number of different
factors.
Streptodornase D (Sda1) and Streptokinase (Ska)
Mutation of the two-component regulator covS found in invasive isolates leads to the
down regulation of speB as well as the up regulation of other secreted virulence factors,
including streptodornase or Sda1, a DNase up-regulated five fold (145). Sda1 is encoded
in a prophage that has been acquired by certain S. pyogenes strains, and thus is unique to
certain M types. It is believed secretion of Sda1 aids in S. pyogenes’ ability to escape the
neutrophil extracellular traps (NETs), that are composed of DNA and are important for
containing bacteria at the initial site of infection (15, 16). Up-regulation of sda1 in
invasive isolates is associated with an increase in NET clearance, and reduction in
neutrophil mediated killing (145). In addition to the up-regulation of known virulence
factors, the down-regulation of speB results in the increased stability of secreted
virulence factors as well as surface associated adhesins and proteins. These surface
associated proteins include plasminogen-binding group A streptococcal M-like protein
(PAM), PAM-related protein (Prp), streptococcal enolase, and glyceraldehyde 3phosphate dehydrogenase, that have all demonstrated the ability to bind human
plasminogen (8, 102, 103, 117). The binding of plasminogen to S. pyogenes’ surface, is
followed by the conversion of the pro-enzyme plasminogen to the active plasmin by
streptokinase (13, 31). Plasmin is a human serine protease that is known to degrade
!

**!

blood cots, extracellular matrix components, and activate additional metalloproteinases
(147). The accumulation of plasmin on the surface of S. pyogenes is believed to be an
important step required for the dissemination of S. pyogenes from the initial infection site
to deeper tissues (30, 135).

Virulence factor regulation in Streptococcus pyogenes
The variety and severity of diseases that S. pyogenes can cause is likely a direct
result of the quantity and variety of virulence factors produced by group A streptococcus.
However, this large arsenal of virulence factors are not all expressed at once, or at the
same level, but rather tightly controlled by a number of transcriptional regulators. These
regulators look to coordinate the expression of virulence genes at the appropriate time so
as to allow for the efficient colonization and infection of the host. Additionally, they also
serve to respond to changes in environment so as to protect the bacteria from any stress
encountered.
Two-component signal transduction systems
One of the most common methods of sensing and responding to the environment
is through a two-component signal transduction system (TCS). TCSs are composed of a
transmembrane bound sensor histidine kinase, and a DNA binding response regulator.
The sensor histidine kinase is often embedded in the bacteria membrane and includes
both intracellular and extracellular regions. Upon recognition of a signaling molecule
outside the cell, the sensor kinase will typically dimerize resulting in the
autophosphorylation of the intracellular domain. The phosphate on the sensor kinase is
then transferred to the cytoplasmic response regulator, activating it as a transcriptional
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regulator. This system thus allows the cell to sense a specific signal, and respond
appropriately by activating the transcription of a specific set of genes (61). To date an
average of 13 TCSs have been identified in S. pyogenes with the most notable being the
TCS CovR/CovS (7, 47, 128).
CovRS or control of virulence TCS is the most characterized TCS in S. pyogenes,
and has been determined to regulate roughly 15% of its genome including a number of
secreted and cell wall associated virulence factors (55). This regulation includes the
control of capsule synthesis as demonstrated by the additional name of this system CsrRS
(capsule synthesis regulator). While still unclear, it is believed activation of this pathway
occurs in response to Mg2+(57), but also may occur in response to general stress (39).
Additional genes regulated by CovRS include the known virulence factors: sagA, sda1,
ska, and speB (28). Regulation of CovRS acts primarily through repression, where
phosphorylated CovR acts to prevent transcription thus explaining the up-regulation of
virulence factors experienced in a covR mutant (28). In addition to the phosphorylation
of CovR, CovS can also function as a phosphatase resulting in the removal of the
phosphate on CovR and the de-repression of genes regulated by CovR. This activity was
determined to be important for survival in stress caused by increased temperature, salt
concentration, or a decrease in pH (39). This complex network is further complicated by
the recent findings that CovR can still function as a regulator in the absence of CovS
(141). This regulation in the absence of CovS is still not clearly understood, but is
believed to occur by phosphorylation of CovR through some unidentified mechanism and
perhaps includes low-molecular-weight compounds such as acetyl phosphate.
Additionally, it is believed that nonphosphorylated CovR is capable of binding promoters
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in the absence of CovS(141). The importance of CovRS regulation is highlighted by the
recent findings that more invasive strains have mutations in this TCS, resulting in global
changes in protein expression. As discussed above, the mis-regulation of specific
virulence factors can result in more virulent bacteria that are able to disseminate causing
severe disease. However, disruption of CovRS regulation can also negatively influence
growth in saliva, suggesting that tight regulation of virulence genes is required for
pathogen fitness (141).
In addition to CovRS other TCS have also been identified and shown to be
important for adaptation to specific environmental conditions. SptRS is a TCS identified
for its importance in growth in saliva, and is believed to regulate the expression of a
number of different metabolic transporters and pathways required for growth and
persistence in saliva (121), while the TCS Ihk/Irr has been shown to be important for
survival and protection against killing by neutrophils (44).
Stand-Alone Response Regulators
In addition to TCS, modulation of gene expression in response to the environment
can also occur by “stand-alone” response regulators. These cytoplasmic transcriptional
regulators are not associated with a sensor kinase, and thus are believed to regulate gene
expression by responding to an intracellular signal. While there are a number of these
regulators encoded in the genome of S. pyogenes the best characterized include Mga and
RopB.
Multiple gene regulator of Group A Streptococcus (Mga)
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Mga was initially identified as the regulator of the important virulence factor and
adhesin, M protein (20). Further characterization of Mga has revealed conservation in all
serotypes, and an important role in regulating genes during exponential growth or initial
colonization (10, 74). This regulation includes a number of cell-wall associated adhesins
and virulence factors involved in evading the host immune response and include in
addition to M protein: streptococcal collagen-like protein, serum opacity factor, C5a
peptidase, and SIC (37, 112). Transcriptome analysis of the Mga regulon in three
different serotypes have demonstrated that 10% of S. pyogenes’ genome is regulated by
Mga, and in addition to identified virulence factors include a number of genes involved in
the transport and utilization of sugar (113). This activation of operons involved in sugar
utilization are important for S. pyogenes growth as demonstrated by a growth defect of a
Mga mutant in chemically defined media containing different sugar sources (113).
Examination of a mga mutant in vivo revealed attenuation in a number of different animal
models as well as a growth defect in biofilms, demonstrating the importance of this
regulation during an infection. (73, 136) (27).
Despite an understanding of the genes regulated by Mga, it remains unclear as to
the signals that trigger expression of Mga’s regulon. Regulation appears to be linked to
growth phase with increased expression of Mga-regulated genes in the presence of
elevated CO2, temperature, sugar sources, or increased iron (19, 93, 105, 107). Analysis
of Mga’s protein sequence reveals a conserved phosphotransferase system (PTS)
regulation domain (PRD) in the center of the protein, and suggests an interaction with the
PTS system in S. pyogenes (64). The PTS system functions to transport sugar into the
cell and might explain the regulation of sugar metabolism by Mga. Direct
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phosphorylation of Mga by the PTS system has yet to be detected, but does raise
interesting questions regarding the direct link between sugar metabolism and virulence
gene regulation.
Regulator of SpeB (RopB)
RopB was first identified as being required for activation of the virulence gene
speB, which encodes a secreted cysteine protease (87). It has also been termed Rgg due to
its homology to proteins in the Rgg family, these proteins function by controlling the
expression of a number of secreted proteins in other Streptococcus species (110, 111,
116). Regulation by RopB was demonstrated to be growth phase dependent with
activation of speB occurring as the bacteria enter stationary phase (97). Identification of
additional genes regulated by RopB also included a number of virulence factors as well
as genes involved in amino acid metabolism (25). However comparison of RopB’s
regulon between different strains has revealed a divergence in RopB function, with only
the conservation of speB regulation between strains (40).
Investigation into the mechanism by which RopB activated transcription
identified two binding sites within the 1 kb region found between speB and ropB (97).
However, ectopic expression of ropB failed to change the growth phase dependent
expression of speB, suggesting additional levels of regulation (97). Recently, it has been
discovered that a number of proteins in the Rgg family found in other Streptococcus
species are activated by small, secreted peptides that function in a quorum-sensing
manner (24, 90). It is believed that small propetides are produced in the cell, secreted,
processed to an active form and then transported back into the cell where they activate
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transcription through a putative interaction with the Rgg protein (24, 90). While RopB is
similar in structure to other Rgg proteins, no signaling peptide has been discovered for it
to date, leaving the mechanism of RopB activation unclear. However, identification of a
novel regulator of speB, LacD.1, has provided interesting insight into speB regulation and
may explain the growth phase dependent expression (82).
Metabolic Regulators
Virulence regulation can occur by a number of different mechanisms, and includes both
TCS as well as the “stand-alone” response regulators described above. However, for
pathogens such as S. pyogenes that is not found in the environment, and has evolved to
colonize and survive on human hosts, common metabolic regulators that typically
function in controlling cellular metabolism have evolved to also regulate virulence gene
expression. This coordination of virulence factor expression and metabolism is
suggestive of the role of virulence factors in nutrient acquisition, and illustrate the
importance of nutrient availability in pathogenesis.
CcpA
Carbon catabolite control in S. pyogenes is regulated by the transcriptional factor
CcpA. This regulator functions to ensure the cell efficiently utilizes the energy sources
available in a hierarchical fashion, often by repressing metabolic pathways involved in
the catabolism of secondary substrates (146). In the presence of a primary substrate,
often glucose, CcpA will bind to catabolite-responsive elements (cre) sites preventing
transcription. This binding is augmented by interaction with the phosphoprotein HPr, a
component of the PTS system. Phosphorylation of HPR at a conserved serine residue by
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HPR kinase, is believed to increase the affinity of HPR for CcpA, and thus enhance
binding to cre sites. HPR kinase activity is regulated by the metabolite, fructose
bisphosphate, thus linking the phosphorylation of HPR to the metabolic state of the cell
(146). In addition to regulating cellular metabolism in S. pyogenes, CcpA has also been
identified as a regulator of key virulence genes including speB, sagA, and slo (124). This
regulation can occur via direct interaction with virulence gene promoters or through the
influence of additional regulatory pathways (72). While glucose often represses genes
via CcpA it has been found that glucose can repress virulence genes in a number of
pathogens as well as S. pyogenes independent of CcpA, suggesting the presence of
additional catabolite sensing pathways (6, 72).
LacD.1
An additional catabolite-sensing pathway recently indentified in S. pyogenes
involves the protein, LacD.1, annotated as a tagatose bisphosphate aldolase. LacD.1 was
initially identified in a transposon screen looking for the de-repression of speB under
conditions identified to inhibit transcription of this gene, in the presence of salt, neutral
pH, or glucose (82). Regulation by LacD.1 has been determined to require key amino
acid residues in the active site necessary for the binding of key metabolic substrates:
fructose bisphosphate, dihydroxyacetone phosphate, and glyceraldehyde 3-phosphate
(82). While the binding of one or more of these metabolic substrates is believed to be
required for regulation, disruption of catalysis does not impede LacD.1’s ability to
function as a regulator, suggesting LacD.1’s enzymatic activity is not necessary for
controlling the transcription of speB (82). One proposed model of regulation, includes a
direct or indirect interaction with RopB, resulting in its inability to activate speB
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transcription. Modulation of this interaction is believed to occur by a change in
concentration of metabolite(s) recognized by LacD.1. Thus in conditions when the
metabolite(s) is abundant LacD.1 is able to sequester RopB, preventing it from activating
the transcription of speB. This model is supported by the early activation of SpeB
expression when ropB is ectopically expressed in a lacD.1 mutant (82).
This novel regulator was initially discovered to control the expression of the
virulence factor speB, however it has also been found to regulate additional genes
including those involved in arginine catabolism (71, 72). The adaptation of LacD.1 as a
novel catabolite-sensing regulator was unique given its similarity to the paralog, LacD.2,
also encoded in the genome of S. pyogenes. Comparisons of LacD.1 and LacD.2 have
found that despite being highly similar in amino acid sequence their functions in the cell
are divergent and unique to each protein (83).
CodY
In response to amino acid starvation, S. pyogenes undergoes what is known as the
stringent response, resulting in the production of the alarmone pppGpp by RelA followed
by pppGpp-mediated inhibition of RNA synthesis protecting the cell from starvation (94).
Additionally, S. pyogenes can respond to amino acid starvation in a RelA independent
manner and involves the transcriptional regulator, CodY (131). CodY is involved in
controlling a number of genes in response to amino acid availability, and include:
transporters of amino acids and peptides, enzymes involved in amino acid metabolism,
additional regulators such as mga, ropB, and covRS, as well as a number of virulence
genes including saga and scpA (89). CodY regulation is controlled by GTP and branched
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chain amino acids (BCAA) and has been demonstrated to bind DNA with higher affinity
in the presence of GTP or BCAA (92). While in most bacteria the response to starvation
includes inhibition of protein synthesis, it is believed that in pathogenic bacteria this
response has been co-opted to also include production of virulence factors involved in the
destruction of eukaryotic cells. Thus, attempting to liberate the necessary metabolic
substrates required for growth. Additionally these virulence factors can also aid in the
spread and dissemination to other tissues that may contain more nutrients (129). This
link between the bacteria’s metabolism and virulence gene expression highlights the
importance of metabolism and its contribution to pathogenesis.

Metabolism of Streptococcus pyogenes
Streptococcus pyogenes belongs to the family Lactobacillacea or lactic acid
bacteria, a wide family of bacteria grouped together by their common metabolic end
product. Lactic acid bacteria include species from the genera Lactobacillus, Lactococcus,
Streptococcus, Pediococcus, Oenococcus, Enterococcus, Lenconstoc, Tetragenococcus,
Vagococcus, and Weissella (3), and are best known for their involvement in the food
industry. Additionally lactic acid bacteria are believed to be common components of
human’s microbiota and play a beneficial role in immunomodulation, intestinal integrity,
and pathogen resistance (142), benefits that have resulted in the use of these bacteria in
probiotics (79). The exploitation of these bacteria in the food industry as well as in
probiotics has resulted in an increase in research examining their physiology and
metabolism. Thus in comparison to S. pyogenes much more is known regarding their
cellular metabolism resulting in them often being used as surrogates for understanding
metabolic pathways present in S. pyogenes.
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Carbohydrate Utilization
The preferred carbohydrate energy source of lactic acid bacteria is glucose,
typically transported through the phosphotransferase systems (PTS), glucose can also be
brought into the cell by additional permeases and ATP-binding cassette (ABC)
transporters (Biotechnology of Lactic Acid Bacteria ref)(138, 139). Glucose transport
through the PTS occurs with phosphorylation of the glucose moiety, which is then
shuttled into the Embden-Meyerhof-Parnas pathway (138)(Figure 3). Catabolism of
glucose by this pathway results in the formation of two molecules of ATP, two molecules
of NADH, and two molecules of pyruvate. In the absence of a respiratory chain, which
lactic acid bacteria lack, for glycolysis to continue the bacteria must re-oxidize NADH so
that it may be recycled and enter the pathway again. This oxidation of NADH occurs via
the metabolism of pyruvate, which can occur by a number of different mechanisms, the
most common occurring through the utilization of the enzyme lactate dehydrogenase
(Ldh). Ldh functions through the conversion of pyruvate to lactate with the concomitant
oxidation of NADH (29). The production of lactate as the major end product is
descriptive of homolactic fermentation as opposed to heterolactic fermentation that
typically occurs under glucose-limiting conditions, and involves the production of
acetate, formate, and ethanol (150). Production of these end products requires additional
enzymes, pyruvate formate lyase in anaerobic conditions and pyruvate dehydrogenase
complex in aerobic conditions, to oxidize NADH with the concomitant production of
acetyl-CoA and formate. Production of acetyl-CoA can be further converted to acetate
by acetate kinase with the formation of a molecule of ATP (1, 98). Additionally, the
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acetyl-CoA can also be converted to acetaldehyde and finally ethanol by the
acetalaldehyde dehydrogenase and alcohol dehydrogenase, respectively.
In addition to glucose, lactic acid bacteria can readily metabolize additional
monosaccharides including galactose. Galactose metabolism can occur by two main
pathways, the most common being the Leloir pathway, involving the isomerization of
galactose 6-phosphate into glucose 1-phosphate, followed by conversion to glucose 6phosphate and reentry into the Embden-Meyerhof-Parnas pathway (62). In Streptococcus
pyogenes, galactose metabolism occurs by the less common, tagatose pathway (Figure 3).
This pathway involves the isomerization of galactose 6-phosphate to tagatose 6phosphate by LacAB, which is then phosphorylated by LacC to produce tagatose
bisphosphate (TBP). This product is then cleaved by an aldolase, LacD, to create the two
three carbon sugars: glyceraldehyde 3-phosphate and dihydroxyacetone phosphate(115).
These three carbon sugars can go on to renter the Embden-Meyerhof pathway and
continue through pyruvate metabolism, which have been shown to involve heterolactic
fermentation in other lactic acid bacteria (137). Examination of the genome of S.
pyogenes has revealed that it encodes two Lac operons dedicated to the metabolism of
galactose (83). However, research in to the function of these two operons has revealed
that while the Lac.2 operon is required for metabolism of galactose, the Lac.1 operon has
evolved to function in the regulation of transcription (83). Specifically, the aldolase in
the Lac.1 operon, LacD.1, has been discovered to function as a novel regulator of
virulence (82). This divergence in function suggests a duplication of the Lac operon
followed by adaptation, and presents itself as an interesting case to study the evolution of
novel protein function.
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While simple sugars are the preferred choice for energy, for most of the pathogens in this
family they must rely on complex carbohydrates for energy in vivo (56, 101, 143).
Colonization of a human nasopharynx by S. pyogenes likely involves utilization of
complex maltodextrins as demonstrated by a decrease in colonization of a mouse
oropharynx by a MalE mutant that lacks the ability to transport maltodextrins, into the
cell (122). In S. pneumoniae, disruption of the transport of sucrose by either an ATPbinding cassette transport system or a sucrose PTS, disrupt the ability to cause pneumonia
or colonization of the nasopharynx, respectively (66). In addition, endoglycosidase and
exoglycosidase play important roles in pathogenesis through both immune evasion
mechanisms as well as nutrient acquisition (17, 123). The utilization of these complex
sugars suggest that the in vivo environment encountered by most pathogenic bacteria is in
stark contrast to the conditions experienced during in vitro growth in a laboratory setting.
Amino Acid Metabolism
Lactic acid bacteria are commonly thought of as nutritionally fastidious given
their lack of an electron transport chain, an incomplete TCA cycle, and their inability to
synthesize many biomolecules, including amino acids. Thus to grow, they must scavenge
their environment for available carbon sources along with the amino acids necessary for
life. Often these amino acids are imported in the cell as dipeptides or short
oligonucleotides. Production of these peptides, and processing of them require a number
of different peptidases with a variety of specificity and functions. While location of these
peptidases in most lactic acid bacteria are believed to occur intracellular (75), S. pyogenes
is known to express and secrete a cysteine protease (SpeB) in high abundance during
entry into stationary phase (97), and during an infection of mouse soft tissue (81). While
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a direct link between nutritional acquisition and the expression of SpeB has never been
found, it is theorized that expression of this protease may aid in accumulating the
essential amino acids required for cellular growth. A theory supported by association
between speB expression, the nutritional environment (108), and the expression of the
dipeptide permease, dpp (106).
While accumulation of these amino acids are required for the biosynthesis of
proteins, amino acid catabolism can also aid in the ability to obtain energy in nutrientlimiting environments. Catabolism of these amino acids can include among others
glutamate, aspartamate, and histidine, although the metabolic pathways of these amino
acids are not all characterized or conserved in every genus of lactic acid bacteria. One of
the most well characterized catabolic pathways is the arginine deiminase pathway (ADI)
that provides energy via substrate level phosphorylation. This pathway involves three
enzymes: 1) ArcA, an arginine deiminase (EC 3.5.3.6), liberates an ammonia molecule
from arginine to create citrulline, 2) ArcB, an ornithine carbamoyltransferase (EC
2.1.3.3) converts citrulline into carbamoyl phosphate and ornithine, and 3) ArcC, a
carbamate kinase (EC 2.7.2.2) generates ATP by transferring the phosphate moiety from
carbamoyl phosphate to ADP. The ornithine produced by ArcB is further utilized by the
antiporter ArcD to transport a new arginine molecule into the cell in an ATP-independent
manner. In addition to the production of ATP, this pathway has been demonstrated to be
important for protection against acid stress as well as aid in survival in stationary phase
(22, 23, 32, 91).
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Furthering studying the evolution of LacD.1 as a novel regulator
The coordination of metabolism and virulence gene regulation highlights how
important the ability to sense the nutritional environment is to a pathogen. While the
onslaught of virulence factors produced by S. pyogenes are directly involved in the tissue
damage and disease caused by this bacteria, the expression of these virulence factors is
often in response to the nutrients available, as well as other important environmental
signals the bacteria can sense. To gain insight into S. pyogenes’ pathogenesis, it is
important to determine what signals are being sensed by S. pyogenes and how these
signals influence virulence gene expression.
Previous research has identified LacD.1 as an important regulator of virulence
gene expression, demonstrating its ability to act as a repressor of the virulence gene speB
as well as an activator of the metabolic pathway involved in arginine catabolism. This
evolution of a metabolic enzyme to a regulator of transcription provides a unique
example to probe how novel protein functions evolve, as well as examine how
metabolism and virulence gene expression are coordinated in S. pyogenes. Furthermore,
understanding the adaptation of LacD.1 can serve as a model system for examining how
proteins evolve novel functions.
This works main focus was to investigate the function of LacD.1 in S. pyogenes.
Through the direct comparison between LacD.1 and LacD.2 we have discovered unique
regions that are important for their respective function, and have gained insight into the
mechanism of LacD.1 regulation. Additionally, through a number of competition
experiments we have identified that the regulatory function of LacD.1 is essential for the
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fitness of S. pyogenes. In addition to examining the evolution of LacD.1, an essential
aspect to understanding LacD.1’s function is investigating the contribution of its regulon
to virulence. The identification of LacD.1’s regulation of the arginine catabolism operon
provides an opportunity to understand how changes in expression of this metabolic
pathway may influence pathogenesis. Through a series of in-frame deletions in the ADI
pathway we have identified the importance of arginine and citrulline catabolism in
pathogenesis, as well as discovered its novel contribution to the modulation of the host
innate immune response.
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CHAPTER II
Adaptive Evolution of the Streptococcus pyogenes Regulatory Aldolase LacD.1.

SUMMARY
In the human pathogenic bacterium Streptococcus pyogenes, the tagatose bisphosphate aldolase LacD.1 likely originated through a gene duplication event and was
adapted to a role as a metabolic sensor for regulation of virulence gene transcription.
Although LacD.1 retains enzymatic activity, its ancestral metabolic function resides in
the LacD.2 aldolase, which is required for the catabolism of galactose. In this study, we
compared these paralogous proteins to identify characteristics correlated with divergence
and novel function. Surprisingly, despite having identical active sites and 82% similarity
in amino acid sequence, LacD.1 was less efficient at cleaving both fructose and tagatose
bis-phosphates. Analysis of kinetic properties revealed that LacD.1’s adaptation was
associated with a decrease in kcat and an increase in Km. Construction and analysis of
enzyme chimeras indicated that non-active site residues previously associated with the
variable activity of human aldolases isoenzymes modulated LacD.1’s affinity for
substrate. Mutant LacD.1’s engineered to have LacD.2-like levels of enzymatic
efficiency lost the ability to function as regulators, suggesting that an alteration in
efficiency was required for adaptation. In competition under growth conditions that
mimic a deep tissue environment, LacD.1 conferred a significant gain in fitness that was
associated with its regulatory activity. Taken together, these data suggest that LacD.1’s
adaptation represents a form of neofunctionalization where duplication facilitated the
gain of regulatory function important for growth in tissue and pathogenesis.
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INTRODUCTION
Adapted metabolic enzymes provide interesting models for examining the role of
gene duplication in driving the process of protein evolution. Derived from metabolic
enzymes, these proteins have been adapted by evolution to perform novel functions that
are not directly associated with catalysis, often functioning as components of
transcriptional regulatory complexes (18). Many of these enzymes are multifunctional,
where the same protein entity participates in both catalysis and regulation (18, 36).
However, others are divergent in function, participating in regulation while no longer
retaining a clear metabolic role (24, 35). The members of this latter class are often the
products of an apparent gene duplication event where the ancestral protein is retained as a
component of the original metabolic pathway. Since the duplicate is initially redundant,
how it avoids the accumulation of deleterious mutations while undergoing adaptation is
not well understood (10). However, the fact that adaptation often results in only minor
alterations to the primary amino-acid sequence and its three-dimensional structure,
suggests that careful comparison of the adapted enzyme and its ancestor can provide
insight into the evolutionary forces driving adaptation. A challenge then becomes the
identification of those specific amino-acid residues whose divergence is associated with
the acquisition of novel functionality.
In Streptococcus pyogenes (group A streptococcus), LacD.1 is an adapted metabolic
enzyme implicated in the transcriptional regulation of several virulence factors, including
the secreted SpeB cysteine protease (26). This Gram-positive bacterium is a human
pathogen responsible for a large number of diseases ranging from largely superficial
infection of the skin and mucous membranes (impetigo, pharyngitis), to highly invasive
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and life-threatening diseases (necrotizing fasciitis), as well as serious post-infection
sequelae (rheumatic fever, glomerulonephritis) and immunopathological syndromes
(PANDAS:

pediatric

autoimmune

neuropsychiatric

disorders

associated

with

streptococcal infection) (reviewed in (8)). Deletion of the gene encoding LacD.1 has been
associated with de-repression of transcription of virulence genes regulated by several
different environmental cues, including pH, salt and carbon source (25). Functionally,
LacD.1 has the characteristics of a tagatose 1,6 bis-phosphate (TBP) aldolase, a
component of the tagatose 6-phosphate pathway used by Gram-positive bacteria to
metabolize lactose and galactose (38). However, the ability to metabolize these
carbohydrates in S. pyogenes resides not in the Lac.1 operon of which LacD.1 is a
member, but rather the nearly identical Lac.2 operon (27). In fact, the Lac.1 operon is
defective, lacking functional copies of the genes encoding several key enzymes, which
instead reside in the operon as pseudogenes. The high degree of homology between the
two operons suggests that the Lac.1 operon arose as a duplication of the Lac.2 operon and
subsequently, the LacD.1 TPB aldolase was adapted for a regulatory role that specifically
required the loss of function of other enzymes in the pathway. This hypothesis is
supported by the fact that restoration of LacC.1 pseudogene function phenocopies
deletion of LacD.1 and that this defective operon architecture is conserved in all S.
pyogenes whole genome sequences that are currently deposited in the Genbank database.
Interestingly, LacD.1 retains the enzymatic activity characteristic of an aldolase, and
has the ability to cleave TBP, and its isomer fructose 1,6 bis-phosphate (FBP) into the
glycolytic intermediates di-hydroxy acetone phosphate (DHAP) and glyceraldehyde 3phosphate (GA3P) (26). However, its ability to participate in transcriptional regulation is
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independent of enzymatic activity, since mutation of a catalytic lysine residue (K204)
abolishes the ability to cleave substrate, but has no effect on its ability to regulate
virulence factor expression. In contrast, mutation of key residues involved in binding
substrate does lead to an abrogation of regulatory activity, suggesting that an ability to
bind substrate is an essential component of LacD.1’s adapted regulatory function (26).
Further support for the specific adaptation of LacD.1 to a regulatory role comes from
the observation that LacD.2 can not substitute for LacD.1 in regulation despite the fact
the two aldolases are 82% similar. Comparison of all aldolases has revealed similarity in
sequence, although they are distributed between 2 general classes that are distinguished
by their mechanism of catalysis (class I and class II) (30). Unlike the metal-requiring
class II aldolases found in most prokaryotes, LacD.1 and LacD.2 are class I enzymes that
utilize a lysine to form a Schiff base intermediate. The crystal structures of LacD.2 in
both its apo form and bound to DHAP and the apo form of LacD.1 have recently been
determined, revealing strong similarity to the well-studied structure of rabbit muscle
aldolase (RMA) (23, 28). All three enzymes share a conserved (!/")8 fold and the
structures show that RMA and LacD.2 undergo a similar conformational response upon
binding DHAP. In addition, the structures show that the LacD.1 and LacD.2 active sites
share an identical sequence. Taken together, these data suggest that LacD.1’s adaptation
to a regulatory function relied upon its original function as an aldolase and that adaptation
involved alterations to residues outside of the active site.
As a first step in understanding how these two similar proteins have been adapted to
diverse function, we sought to compare and contrast various properties of LacD.1 and
LacD.2 in order to identify characteristics unique to each enzyme.
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We found that

LacD.1’s adaptation is associated with a measurable divergence in catalytic function and
that this altered enzymatic activity is necessary for its adapted regulatory function.
However, an altered enzymatic activity is not sufficient to account for LacD.1’s
divergence, as its regulatory function requires additional variant residues. LacD.1, but
not LacD.2, was found to confer a significant competitive advantage under growth
conditions that mimic a deep tissue environment. Furthermore, this gain in fitness did not
depend on its divergent catalytic properties, but was specifically associated with its
regulatory activity. Thus, these data provide insight into the molecular basis of the
evolution of LacD.1’s novel regulatory function.
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RESULTS
LacD.1 and LacD.2 are structurally similar. Recently, crystal structures of LacD.1
and LacD.2 from S. pyogenes (PDB codes 3MYO and 3MHF, respectively) have both
been solved (23, 28), but have not been directly compared. To compare the tertiary
structures of the aldolases, the algorithm FATCAT was utilized to allow for an alignment
that takes flexibility into consideration (44). This comparison indicated that the two
proteins were significantly similar (P < 0.001) with an r.m.s.d of 1.0 (C! atoms) (Fig.
1A) and that the positioning of active site residues between the apo forms of the two
enzymes are essentially identical (Fig. 1B).
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LacD.1 has a higher Km for substrate than LacD.2. Given that LacD.1 and LacD.2
share identical active site residues and nearly identical three-dimensional structures,
aldolase activity was directly compared to determine if LacD.1’s divergent function was
associated with any variation in enzyme efficiency.

Activity was assessed using a

standard enzyme-coupled assay linking cleavage of the phosphorylated sugar to oxidation
of

!-NADH

by

glycerol-3-phosphate

dehydrogenase,

which

was

measured

spectroscopically. This analysis revealed that LacD.2 readily cleaved both TBP and FBP
(Table 1) at rates similar to those reported previously (28) and similar to the class II TBP
aldolase found in E. coli (43). When the S. pyogenes enzymes were compared, the kcat of
LacD.1 was similar to that of LacD.2, although slightly lower for both substrates
(approximately 1.5-2-fold, Table 1). In contrast, Km for LacD.1 was approximately fourtimes higher than for LacD.2, indicating a considerable decrease in affinity for both TBP
and FBP (Table 1). Considering that the two enzymes share identical active sites, these
data demonstrate that LacD.1’s adaptation to a regulatory role is associated with a
roughly 6-8 fold decrease in enzyme efficiency as calculated by kcat/Km (Table 1). These
data also suggest that variant non-active site residues influence LacD.1’s divergent
properties.
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Reaction pH has a similar influence on both LacD.1 and LacD.2. The observation
that pH is one signal that modulates LacD.1-dependent regulation (26) suggested that
adaptation may have involved a modification to a pH-sensitive step associated with
LacD.1’s differential catalytic activity. To test this, steady-state kinetic parameters for
FBP cleavage were determined over a range of pH values that reflect those encountered
by S. pyogenes during infection. Comparison of enzyme efficiency revealed a decrease
for LacD.1 at every pH value tested (Fig. 2). However, the profiles for LacD.1 and
LacD.2 resembled similar bell-shaped curves, with optimum enzyme efficiency occurring
at pH 6.8 and efficiency decreasing at both more acidic and basic solution conditions
(Fig. 2). Although two different buffer systems were required for the full range of pH
values analyzed, measurement of activity of each buffer at their overlap (pH 6.8)
produced similar results for both enzymes, indicating that the buffer composition had no
measurable influence on catalysis (data not shown). Comparison of the apparent pKa and
pKb of both enzymes revealed essentially identical values (Fig. 2). Thus, pH has a similar

58

influence on catalysis for both LacD.1 and LacD.2, suggesting adaptation did not require
a change in LacD.1’s catalytic mode.

Catalysis is not influenced by changes in enzyme concentration. Class I aldolases
in higher eukaryotes typically function as homotetramers with an extremely low
oligomerization constant (42) with quaternary structure linked to enzyme thermostability
(3) and non-catalytic aldolase function (39). However, to determine if a change to
oligomeric state is associated with altered enzymatic activity, LacD.1 and LacD.2
quaternary structure was compared. Analysis using size-exclusion chromatography
revealed that both proteins eluted as a single peak with a nearly-identical elution volume
(Fig. 3). The calculated apparent molecular weight for LacD.1 and LacD.2 was 67±3 and
71±3 respectively, close to the expected molecular weight for a dimer (75 kDa, LacD.1;
76 kDa, LacD.2) and consistent with the crystallization of each as homodimers (23, 28).
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To investigate if enzyme concentration influences catalysis, the FBP aldolase activity of
both LacD.1 and LacD.2 was measured at six different concentrations ranging between
100 nM to 5 mM. Plots of enzyme activity as a function of enzyme concentration
revealed a linear relationship for both LacD.1 and LacD.2 (Fig. 4), suggesting that the
differential activity of LacD.1 is not the result of a concentration dependent change in
activity. Taken together, these data suggest that adaptation did not involve major changes
to the quaternary structure of LacD.1.
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The C-terminus of LacD.1 contributes to its differential enzymatic activity. To
determine the amino acid residues involved in LacD.1’s differential catalytic activity, the
divergent LacD.1 residues were mapped onto the structure of LacD.2. This comparison
revealed that these residues were located predominantly on the surface of the enzyme
(Fig. 5). However, they were not noticeably clustered in any specific region, but rather
were dispersed throughout the protein (Fig. 6). Thus, in the absence of any obvious
candidate residues involved in the differential activity, several chimeric proteins were
created that swapped extended contiguous regions of LacD.1 with the corresponding
LacD.2 region (Fig. 6) followed by analysis of their steady state kinetic properties (Table
1). Initially LacD.1 was bisected, replacing its C-terminal half with 162 amino acid
residues from the C-terminus of LacD.2 (LacD.12A, Fig. 6). This enzyme behaved very
similar to LacD.2 in the cleavage of TBP, but was over 3 times more efficient than
LacD.2 at cleaving FBP, as measured by the quotient (kcat/Km) (Table 1).
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The increase in enzyme activity by LacD.12A as compared to LacD.1 suggested the
residues in the C-terminus contributed to the decreased activity displayed by LacD.1. To
help further identify the specific residues involved in modulating LacD.1’s enzymatic
activity two smaller swaps were made, LacD.12B and LacD.12C (Fig. 6), resulting in the
exchange of either 19 or 13 polymorphic residues, respectively. Comparison of LacD.12B
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to LacD.2 revealed the enzyme was similar in activity in cleaving FBP, but less efficient
at cleaving TBP due to a lower kcat (Table 1). LacD.12C exhibited a decrease in the Km
for both TBP and FBP compared to LacD.1 (Table 1). However, compared to LacD.12B
or LacD.2, LacD.12C was less efficient at cleaving both FBP and TBP due to a relative
increase in Km, suggesting that the 13 polymorphic residues mutated in LacD.12C, as well
as the 6 additional polymorphic residues mutated in LacD.12B, contribute to the
enzymatic efficiency of LacD.1. Taken together, comparison of the chimeric enzymes
illustrate that polymorphic residues found throughout the C-terminus half of LacD.1
contribute to its decrease in enzymatic activity, primarily by influencing LacD.1’s Km for
both TBP and FBP, and to a lesser extent the turnover number or kcat for both substrates.
Examination of the polymorphic residues swapped on the crystal structures of LacD.1
and LacD.2 revealed that the identified residues primarily clustered into two structural
regions. The first region, Loop 1, connects the ninth alpha helix to the eighth beta sheet
and contains 4 polymorphic residues. The second region, Turn 2, connects the tenth helix
to the eleventh helix (Fig 5) and contains 6 polymorphic residues including a proline that
changes position and likely influences the flexibility of the protein (Fig. 6).
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Loop 1 and Turn 2 influence the differential enzymatic activity of LacD.1. To
determine the role of these two structural regions in the enzymatic activity of LacD.1, the
amino acid sequence of the LacD.1 Loop 1 or the Turn 2 region were swapped with the
corresponding LacD.2 sequence.

The two enzyme’s catalytic activities were then

characterized and compared to LacD.1 and LacD.2.

Mutation of Loop 1 to create

LacD.12(L1) (Fig. 6) resulted in an enzyme with a considerably lower Km for both FBP and
TBP compared to LacD.1 along with an increase in kcat for FBP (Table 1). However, the
Loop 1 chimera remained less efficient than LacD.2 in cleavage of both phosphorylated
sugars. The Turn 2 chimera, LacD.12(T2) (Fig. 6), also resulted in an enzyme that was
more efficient for cleavage of both substrates than LacD.1, although not to the same
extent as LacD.2 (Table 1). To examine the contribution of these two structural regions
together an additional chimera was constructed to introduce both the LacD.2 Loop 1 and
Turn 2 into LacD.1 (LacD.12(L1+T2), Fig. 6). The swap of both regions generated an
enzyme with activity comparable to LacD.2 for FBP (Table 1), but was less efficient at
cleaving TBP due to a lower kcat and a slightly higher Km. (Table 4). Chimeras with the
reciprocal swaps to exchange the LacD.2 Loop 1 and Turn 2 into LacD.1 were
constructed, however, expression of these in E. coli resulted in low yields and proteins
that were insoluble (LacD.21(L1+T2), Fig. 6; Supplementary Fig. 1). This protein instability
was further seen with replacement of LacD.2’s 36 C-terminal residues to LacD.1
(LacD.21F, Fig. 6; Supplementary Fig. 1). Additionally, a LacD.2 chimera was created,
that replaced the LacD.2 residues 165 through 260 with the LacD.1 sequence leaving
intact both LacD.2’s Loop 1 and Turn 2 sequences (LacD.21G , see Fig. 8 below). Kinetic
analysis of this aldolase revealed that for both FBP and TBP this enzyme behaved similar
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to LacD.2 (Table 1). Taken together these data indicate: 1. That the residues responsible
for divergent activity reside in the C-terminal half of LacD.1; 2. That the polymorphisms
in Loop 1 and Turn 2 make a major contribution to differential catalysis of TBP by
LacD.1 due to an increase in the enzyme’s Km and a decrease in the kcat; and 3. That the
LacD.2 Loop 1 and Turn 2 do not completely restore LacD.1’s catalysis of TBP, with
enzyme efficiency remaining approximately four-fold lower than for LacD.2.
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The polymorphic residues responsible for differential enzyme activity contribute to
regulatory function. The adaptation of LacD.1 to a regulator resulted in an aldolase with
decreased enzyme efficiency. However, it is unclear if this decrease in aldolase activity
was necessary for adaptation or coincidental. To begin to answer this question the ability
of the chimeric enzymes to regulate a virulence factor, the secreted cysteine protease,
speB was examined. Expression of SpeB is routinely monitored on protease indicator
plates, where the diameter of zone of clearing around bacterial growth in milk-containing
media results from the proteolytic cleavage of casein reflecting the amount of SpeB
produced (WT, Umod., Fig. 7A). However, buffering the medium to pH 7.5 results in
repression of speB transcription ((25)) and a loss of the halo (HSC5 Empty Vector, pH
7.5, Fig. 7). In contrast, speB expression is derepressed in a LacD.1 null mutant under
these conditions ("LacD.1 Empty Vector, pH 7.5, Fig. 7A) and the wild type phenotype
can be complemented by introduction of a plasmid expressing LacD.1, but not LacD.2
(compare pLacD.1 to pLacD.2, pH 7.5, Fig. 7A). To determine the influence of
polymorphic residues on this regulatory activity, plasmids encoding various chimeric
enzymes were tested for the ability to complement a LacD.1-deficient mutant.
Expression of the bisected chimera (LacD.12A), which has LacD.2-like enzymatic
properties, revealed a similar regulatory phenotype to LacD.2, as it was unable to repress
expression of SpeB (Fig. 7A, 7B). In contrast, the chimera with only the 67 C-terminal
residues of LacD.2 (LacD.12B) and reduced enzyme efficiency was fully functional in
regulation with a phenotype similar to LacD.1 (Fig. 7A, 7B). Swaps of the 40 C-terminal
residues (LacD.12C) or the individual regions of Loop 1, Turn 2, or Loop 1 & Turn 2 did
not alter LacD.1’s ability to regulate SpeB expression, as similar to WT or pLacD.1, no
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halo formed around growth at pH 7.5 on the indicator plates (Fig. 7A). Measurement
utilizing a more quantitative FITC-Casein cleavage assay to measure SpeB activity
following growth in liquid media revealed that chimeras containing the LacD.2 Turn 2
(LacD.12C and LacD.12(T2) ) were even more effective repressors than LacD.1, as they
exhibited a super-repressor phenotype by producing significantly less SpeB activity (Fig.
7B). Interestingly, super-repression was abrogated when the LacD.2 Turn 2 was
combined with the cognate LacD.2 Loop 1 residues as chimeras with matched domains
had regulatory activity identical to LacD.1 (LacD.12(L1+T2), Fig. 7). This context
dependent super-repressor phenotype along with the influence of these domains on
aldolase activity (see above) suggests that the polymorphic residues in Loop 1 and Turn 2
are functionally coupled. Taken together, these data indicate that chimeras with LacD.2
levels of catalytic efficiency lacked the ability to function as regulators. This latter
property was only associated with those chimeras that have a four-fold or greater
decrease in efficiency for cleavage of TBP.
Extensive regions of LacD.1 are required for regulatory activity. The ability of
LacD.12B to function as a regulator and the inability of LacD.12A to complement a LacD.1
mutant suggested that variable residues within the 94 amino acid sequence located in the
center of LacD.1 are necessary for its regulatory function. To determine if these residues
are sufficient an additional chimera was constructed to swap the LacD.1 region into
LacD.2 (LacD.21G, Fig. 8A). However, when examined on indicator plates and in liquid
culture, this chimera was unable to repress expression of SpeB (Fig. 8B, 8C), suggesting
additional variable residues within the N-terminus are required.
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Three additional

chimeric enzymes were then constructed to swap larger regions of LacD.1 into the
LacD.2 sequence (Fig. 8A).
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Neither the introduction of 126 or 173 LacD.1 residues was able to generate a chimera
with regulatory activity (LacD.21H , LacD.21I ; Fig. 8b, 8C). Furthermore, a final chimera
which swapped the 87 N-terminal residues of LacD.1 along with the central 94 amino
acid region into LacD.2 also did not gain regulatory activity (LacD.21J, Fig. 8B, 8C).
These data suggest that multiple polymorphic residues dispersed through out LacD.1 are
required for its function as a regulator.
The adaptation of LacD.1 results in increased fitness. In order to determine if
LacD.1’s adaptation is associated with any selective advantage, competition analyses
were performed using culture conditions formulated to mimic growth in a deep tissue
environment (25). This analysis was conducted by complementing "LacD.1 with
plasmids that expressed LacD.2 or selected enzyme chimeras. These plasmids were
identical in all other respects, including the ectopic promoter driving expression of the
chimeric gene and the kanamycin and chloramphenicol resistance determinants. An
exception was the plasmid for the competitor strain, which expressed LacD.1 as above,
but lacked the kanamycin-resistance determinant (pLacD.1-kan). A co-culture was then
initiated between the competitor strain ("LacD.1 with pLacD-kan) and a test strain
expressing one of the chimeric enzymes. The number of colony forming units for each
strain was then enumerated following serial passage of the culture over a period of
several days. As measured by the competitive index, the LacD.1 test strain had fitness
equivalent to that of the competitor (pLacD.1-kan) over a 4-day period (pLacD.1, Fig. 9).
In contrast, the LacD.2 test strain had a loss of fitness that was apparent by Day 2 that
continued to decline precipitously, achieving a net decrease of 4 logs by Day 4 (pLacD.2,
Fig. 9). Test strains expressing LacD.1 chimeras with increased catalytic properties, but
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intact regulatory activity, demonstrated no loss of fitness over the period of observation
(pLacD.12B, pLacD.12C; Fig. 9). However, when the chimera tested also lacked regulatory
activity, it also lost fitness in a pattern identical to the LacD.2 test strain (pLacD.12A, Fig.
9). These data demonstrate that LacD.1 makes an important contribution to fitness, and
that mutations in the C-terminus linked to increased enzymatic activity did not influence
this fitness under the conditions tested.

Taken together, these results implicate its

regulatory activity in LacD.1’s contribution to fitness.
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DISCUSSION
Comparison of protein paralogs with divergent functions can provide detailed
information regarding the structure/function relationship of each protein as well as insight
into the evolutionary mechanism that resulted in novel protein function. In this study,
comparison of the paralogs LacD.1 and LacD.2 has revealed that while these enzymes
share extensive sequence identity and structures, they are divergent with regards to their
enzymatic properties and overall functions. The polymorphic residues associated with
divergent catalytic activity were primarily confined to two discrete segments. However,
the residues responsible for LacD.1’s novel regulatory function were more widely
dispersed. Furthermore, LacD.1’s less efficient catalytic activity was associated with its
ability to function as a regulator. Together these data provide insight into the specific
functions of LacD.1 and LacD.2 and into the evolutionary process that fostered their
divergence.
One interesting insight came from the observation that the Loop 1 and Turn 2 features
were functionally coupled. This is consistent with studies showing that protein evolution
can be driven by networks of statistically coupled amino acids, termed sectors, that coevolve throughout protein families (11, 41). Sectors may be linked to conservation of
specific function, including enzymatic reactions or substrate-binding motifs, and thus,
constitute fundamental units of evolution for repurposing to novel function. Examples of
specific sectors include conserved networks for allosteric regulation of enzymes that link
residues on the surface of the protein to the active site (37). While the residues within the
sector can continue to change, their coevolution allows allosteric regulation to remain
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intact. Similar to what was observed for LacD.1 and LacD.2, cognate sectors can be
adapted in order to modulate an enzymes activity (37).
This mechanism of variation has also been reported for other families of aldolase
enzymes, suggesting a common mechanism underlays the evolution of the S. pyogenes
enzymes. Similar to the streptococcal enzymes, the aldolases found in higher eukaryotes
are 70% identical and have identical active sites, yet they can have divergent activity with
respects to their substrates. Mutational studies have shown that the residues responsible
for differential activity are clustered in two specific patches, the terminal surface patch
(TSP) and the distal surface patch (DSP), that are distal to their active sites (2, 20, 21,
31). Examination of cysteine reactivity and the analysis of crystal structure B-factors
suggest that these two patches influence flexibility to coordinate motion of the enzyme
(14, 33, 34). Comparison of these aldolase isozymes to the S. pyogenes enzymes reveals
that the polymorphic residues of Turn 2 adjacent to helix 10 and helix 11 and across from
helix 2 correspond to a region within the TSP. Thus, Turn 2 could have a similar
influence on movement. An increase in motion could explain the increase in the Km as a
result of the higher entropic penalty accompanying binding. Additionally, a disruption in
the coordination of the protein motions that are required for substrate binding could also
be a contributing factor. Taken together, these similarities suggest that Loop 1 and Turn
2 are sectors that are constituents of an allosteric network in type 1 aldolases.
Conservation of an allosteric network in type I aldolases further supports the
hypothesis that these enzymes evolved from a common ancestor. Structural comparison
of LacD.2 and rabbit muscle aldolase revealed a strong conservation of active site and
catalytic residues (28), with the absence of the flexible C-terminal region found on class I
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FBP aldolases being the largest deviation in structure. This C-terminus region aids in
product release and likely contributes to LacD.2’s decrease in FBP cleavage rate
compared to other FBP aldolases.

Interestingly the LacD.12A chimera showed an

increase in cleavage of FBP compared to LacD.2 suggesting that polymorphic residues
found between 163 and 258 have an influence on catalysis. However swapping this
region in LacD.2 to create LacD.21G did not drastically influence this enzyme’s activity
toward TBP or FBP. The epistatic nature of these residues suggests that additional amino
acids found in the N-terminus of LacD.1 are functionally linked to this region and the
enzymatic activity of the aldolase. Furthermore, given that the residues in this region are
required for the regulatory function of LacD.1, this further suggests that the adaptation of
LacD.1 into a metabolic sensor required the co-evolution of multiple amino acid residues.
Often, the best option for informing the cell of its metabolic state are enzymes that
have evolved to be sensitive to the concentration of a specific metabolite (6, 13, 40).
Thus, an important question is whether the manipulation of allostery to repurpose
enzymes for alternate enzymatic activity can also be used for the adaption to more
diverse functions, including roles as transcriptional regulators and/or metabolic sensors.
Investigation into a number of different bacteria and regulatory pathways has found a
variety of examples by which metabolic enzymes have evolved to function in a
regulatory fashion.

In the case of PutA, a proline degrading enzyme found in

enterobacteria, the acquisition of a DNA binding domain has allowed this protein to
function both as a metabolic enzyme and transcriptional regulator through direct
interaction with DNA. This regulation is controlled by the presence of proline that leads
to a distinct conformational change in the protein that changes its localization in the cell
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and the ability to bind DNA (32). Alternatively, in E. coli the regulation of the maltose
pathway has evolved through a number of protein-protein interactions of enzymes in the
pathway that sequester the transcriptional activator MalT in the absence of substrate (17).
Additionally the human aldolase isozymes that are expressed in a specific tissue manner
have also acquired secondary interactions with cytoskeleton proteins expressed in these
tissues. These interactions occur in and near the active site of the aldolase and thus are
also regulated by the presence of substrate. Interestingly the tissue specific aldolases
have increased specificity for the cytoskeleton proteins expressed in the tissue in which
they are expressed, suggesting an additional role of the isozyme specific residues (19,
20).

Together, these examples suggest that evolution has routinely drawn upon an

enzyme’s ability to recognize a metabolic substrate to link the structural changes that
occur with binding to a regulatory output. Comparison of these examples to LacD.1
highlights some key similarities and differences. Previous mutagenesis studies examining
LacD.1 have shown that catalysis does not contribute to its regulatory function, but that
disruption of the ability to bind substrate does result in loss of regulatory activity (26),
suggesting LacD.1’s evolution likely required retention of the ability to accurately sense
a phosphorylated sugar substrate. However, noticeably different from the previous
examples is the division of the metabolic and regulatory function between two proteins.
Occasionally, the acquired secondary regulatory function can coexist with the enzyme’s
primary metabolic role, however in instances when these two functions are mutually
exclusive, gene duplication can serve to resolve this conflict.
Adaptation that acts to harness an enzyme’s ability to sense a metabolite to a
transcriptional regulatory output often occurs subsequent to a gene duplication event.
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However, the most common fate of the initially redundant gene is that it accumulates
deleterious mutations leading to gene death (7). Thus, retention of the duplicate requires
that it is adapted to provide a selective advantage for the organism. In this regard,
LacD.1’s adaption may share some features in common with the well-characterized GAL
network in the yeast Saccharomyces cerevisiae, in which an adapted galactose kinase
functions as the sensory component of a transcriptional regulatory complex.

This

adapted enzyme is apparently the product of a gene duplication event and comparisons to
the ancestral enzyme found in related yeasts have suggested that duplication was
necessary in order resolve an adaptive conflict that arose when positive selection for
regulatory activity proved deleterious to enzymatic function. The ancestral enzyme has
dual functionality, with a limited ability to act both as a transcriptional regulator and as a
galactose kinase. However, in S. cerevisiae, duplication promoted a process of subfunctionalization that partitioned regulatory and enzymatic activity between the two
genes. This “escape from conflict” then allowed positive selection to optimize each of
these individual functions. In the streptococci, it is not yet known whether regulatory
function is unique to LacD.1 of S. pyogenes or whether it was derived from an ancestor
with dual function.

However, since one of LacD.1’s regulatory targets, the SpeB

protease, is unique to S. pyogenes, it is possible that LacD.1’s regulatory activity is also
novel and thus, its adaptation may be distinct from that of the yeast enzyme. In this
scenario, an escape from conflict would have promoted neofunctionalization, where
instead of partitioning and perfecting existing functions, the gene would gain a novel
function.
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Another distinction is that while the subfunctionalization of the yeast regulatory
paralog resulted in the loss of its galactose kinase activity (35), LacD.1 retains an
aldolase activity. Interestingly, an increase in aldolase efficiency to levels comparable to
LacD.2 resulted in a loss of activity. Currently it is unclear whether these residues have a
direct role in regulation or if an increase in activity indirectly influences LacD.1’s
regulatory function; it is possible that the reduced efficiency of LacD.1’s catalytic
activity represents sub-functionalization of catabolic activity between LacD.1 and
LacD.2. For the yeast regulatory paralog, it has been shown that both the partitioning of
regulatory activity and the loss of enzymatic activity each contributes to significant gains
in fitness (15, 24). However, the gain of fitness provided by LacD.1 appears to be
associated with a gain in regulatory activity acquired concomitantly with a decrease in
enzymatic activity. Thus, while LacD.1’s decrease in enzymatic activity toward TBP
represents subfunctionalization, the polymorphisms that occur in Loop 1 and Turn 2
region of LacD.1, and their associated role in enzymatic activity is not clear. In the
present study, we examined fitness under conditions that mimicked growth in soft tissue,
which is relatively poor in its content of carbohydrates that can be metabolized by S.
pyogenes.

This is likely not the case at other sites that can support streptococcal

colonization. Thus, an alternative is that rather than being required for LacD.1’s function
during growth in deeper tissue, polymorphisms in Loop 1 and Turn 2 may be required to
maintain fitness under carbohydrate-rich conditions where the Lac.2 operon is highly
expressed. An inappropriate aggregate level of aldolase activity could alter the flow of
carbon through the glycolytic pathway or altered the fine balance of regulation of the
Lac.2 operon relative to other carbohydrate processing pathways.
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LacD.1’s regulatory function has been demonstrated to include genes expressed both
in exponential and early stationary phase(1). This study represents the initial stage of an
investigation into the complex evolutionary process that resulted in LacD.1’s novel
protein function. Taken together, the data suggest that LacD.1’s adaptation represents a
form of neofunctionalization where duplication facilitated the gain of regulatory function
important to growth in tissue and pathogenesis. However, confirmation of this idea will
require further investigation into a number of different areas, including an understanding
of the molecular details of how LacD.1 acts to control transcription and its partners in the
regulatory pathway. This information will prove invaluable for identification of residues
that are specifically required for LacD.1’s regulatory function and the role of selection in
divergence at these positions relative to LacD.2. The rapid accumulation of sequence
from additional S. pyogenes strains and from other streptococcal species will allow a
higher resolution analysis of selective pressure on individual residues and should provide
insight into the relative contributions of subfunctionalization vs neofunctionaliztion in the
evolution of virulence in S. pyogenes.
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Supplementary Table I. Strains used in this studya
Strains
E. coli
JL266
JL268
ZC81
ZC209
ZC227
ZC282
ZC283
ZC318
ZC240
ZC364
ZC214

Relevant genotype

Plasmid

Description

Reference

Expression of LacD.1-His
Expression of LacD.2-His
Expression of LacD.12A-His
Expression of LacD.12B-His
Expression of LacD.12C-His
Expression of LacD.12(L1)-His
Expression of LacD.12(T2)-His
Expression of LacD.12(L1+T2)-His
Expression of LacD.21F-His
Expression of LacD.21(L1+T2)-His
Expression of LacD.21(L1+T2)-His

Loughman et al. (2006)
Loughman et al. (2006)
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work

BL21(DE3)
BL21(DE3)
BL21(DE3)
BL21(DE3)
BL21(DE3)
BL21(DE3)
BL21(DE3)
BL21(DE3)
BL21(DE3)
BL21(DE3)
BL21(DE3)

pJL132
pJL134
pZC15
pZC53
pZC54
pZC79
pZC80
pZC99
pZC64
pZC116
pZC55

HSC5

wild-type

none

wild-type

Hanski et al. (1992)

ZC369

pLZ12

HSC5 (vector)

This work

JL151

wild-type
HSC5 lacD.1!21-321

none

In-frame deletion of lacD.1

Loughman et al. (2006)

ZC374

HSC5 lacD.1!21-321

pLZ12

JL151 (vector)

This work

JL340

HSC5 lacD.1!21-321

pJL154

JL151 (pLacD.1-HA)

Loughman et al. (2006)

JL342

HSC5 lacD.1!21-321

pJL156

HSC5 lacD.1!21-321

pJL162

JL151 (pLacD.2-HA)
JL151 (pLacD.12A-HA)

Loughman et al. (2006)

JL347
ZC719

HSC5 lacD.1!21-321

pZC206

JL151 (pLacD.12B-HA)

This work

ZC714

HSC5 lacD.1!21-321

pZC207

JL151 (pLacD.12C-HA)

This work

ZC451

HSC5 lacD.1!21-321

pZC127

JL151 (pLacD.12(L1)-HA)

This work

ZC452

HSC5 lacD.1!21-321

pZC128

JL151 (pLacD.12(T2)-HA)

This work

ZC453

HSC5 lacD.1!21-321

pZC129

JL151 (pLacD.12(L1+T2)-HA)

This work

ZC715

HSC5 lacD.1!21-321

pZC208

JL151 (pLacD.21G-HA)

This work

ZC716

HSC5 lacD.1!21-321

pZC209

JL151 (pLacD.21H-HA)

This work

ZC717

HSC5 lacD.1!21-321

pZC210

JL151 (pLacD.21I-HA)

This work

ZC718

HSC5 lacD.1!21-321

pZC211

JL151 (pLacD.21J-HA)

This work

S. pyogenes

This work

a. Gene names are based on current annotation of the genome of S. pyogenes SF370 in the
NCBI database (http://www.ncbi.nlm.gov).
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Supplementary Table II. Primers used in this study
Name

Sequencea

JLP104

TAAAGAATTCTATCAGCAACTTCAAGTAAG

JLP173

ATCACACTGCAGTTAAGCATAATCTGGAACATCATATGGATAGATTTTTTCCGTCCAAGG

JLP130

CAATGAATTCAAGTCAAAGAGGTATAAAAAATG

JLP174

TTTCTTCTGCAGTTAAGCATATCTGGAACATCATATGGATACATTTTTTCAGTCCAAGG

JLP165

GAGACCATGGACATGACAAATCACAGT

JLP166

GGTTCTCGAGGATTTTTTCCGTCCAAGG

JLP167

GAGGCCATGGAAATGACAATTACTTTAAC

JLP168

AATACTCGAGCATTTTTTCAGTCCAAGG

OJOY3S

GGGGTCCCTTTCCTTGATAG

JLP160

AAAGCTCGAGAAAAAAAGGGATGTCTTC

OJOY37

CTGCACTTTGTTATTTACCAATACC

JLP161

CTACCTCGAGATTCTAACTTATGATG

ZC34

GAGACCATGGACATGACAATAACAGC

ZC33

AATAGTCGACCATTTTTTCAGTCCAAGG

JLP165

GAGACCATGGACATGACAAATCACAGT

ZC99

/5PHOS/GCCTGCACTCAAATAGATAT

ZC100

/5PHOS/GTTTCTGCCAAATTGTTCCA

JLP168

AATACTCGAGCATTTTTTCAGTCCAAGG

JLP165

GAGACCATGGACATGACAAATCACAGT

ZC104

/5PHOS/GGATCCTGCCCACGTGGCACGCC

ZC103

/5PHOS/GTAAAAGTCTATATCGAAGAAGG

JLP168

AATACTCGAGCATTTTTTCAGTCCAAGG

ZC117

CAAGAGACATTATACTTTGCAGCAGAATCAGGTGCTCAATTTAGTGG

ZC118

CCACTAAATTGAGCACCTGATTCTGCTGCAAAGTATAATGTCTCTTG

ZC169

CTTTGCAGCAGAATCAGGTGCTAAATTTAACGGTGTTTTGTGTGG

ZC170

CCACACAAAACACCGTTAAATTTAGCACCTGATTCTGCTGCAAAG

ZC85

GCCACGTGGGCAGGATCCGTTAAAGTTTATATTACTAAAGG

ZC86

CCTTTAGTAATATAAACTTTAACGGATCCTGCCCACGTGGC

ZC157

CAGGATCCGTTCCAGTTTATATTACTAAAGGACCGCAGGCAGCAAGAAAGTGGCTATGCAC

ZC158

GTGCATAGCCACTTTCTTGCTGCCTGCGGTCCTTTAGTAATATAAACTGGAACGGATCCTG

ZC171

GCCACGTGGGCAGGATCCGTTAAAGTTTATATTGAGGAGGGACCGCAGGCAGCAAG

ZC172

CTTGCTGCCTGCGGTCCCTCCTCAATATAAACTTTAACGGATCCTGCCCACGTGGC

ZC157

CAGGATCCGTTCCAGTTTATATTACTAAAGGACCGCAGGCAGCAAGAAAGTGGCTATGCAC

ZC158

GTGCATAGCCACTTTCTTGCTGCCTGCGGTCCTTTAGTAATATAAACTGGAACGGATCCTG

ZC85

GCCACGTGGGCAGGATCCGTTAAAGTTTATATTACTAAAGG

ZC86

CCTTTAGTAATATAAACTTTAACGGATCCTGCCCACGTGGC

ZC171

GCCACGTGGGCAGGATCCGTTAAAGTTTATATTGAGGAGGGACCGCAGGCAGCAAG

ZC172

CTTGCTGCCTGCGGTCCCTCCTCAATATAAACTTTAACGGATCCTGCCCACGTGGC

JLP130

CAATGAATTCAAGTCAAAGAGGTATAAAAAATG

ZC128

/5PHOS/TCCTTCTTCGATATAGACTTTTAC

ZC130

/5PHOS/GAGGACGAAGCAAGAAAGTGGCTATG

JLP166

GGTTCTCGAGGATTTTTTCCGTCCAAGG

ZC173

ATTTGCAGCATCAGGTGCTCAGTTCAGCGGTGTCTTATGTGGACG

ZC174

CGTCCACATAAGACACCGCTGAACTGAGCACCTGATTCTGCTGCAAAT

ZC175

GGGCAGGATCTGTAAAAGTCTATATCGAAGAAGGAGAGGATGAAGCTCGTGAATGGTTGCG

ZC176

CGCAACCATTCACGAGCTTCATCCTCTCCTTCTTCGATATAGACTTTTACAGATCCTGCCC

ZC177

CTACCTGGGCAGGATCTGTACCAGTCTATATCGAAGAAGG

ZC178

CCTTCTTCGATATAGACTGGTACAGATCCTGCCCAGGTAG

ZC182

GGGCAGGATCTGTAAAAGTCTATATCACGAAAGGACCACAAGCAGCTCGT

ZC183

ACGAGCTGCTTGTGGTCCTTTCGTGATATAGACTTTTACAGATCCTGCCC

JLP162

GAATCTCGAGGTAGAATGGAATATCTTC

OJOY3S

GGGGTCCCTTTCCTTGATAG

OJOY37

CTGCACTTTGTTATTTACCAATACC

JLP159

TTTTTCTCGAGCTTTTGAGTTATGATGAG

Template

Plasmid

Description

HSC5

pJL155

Primers for expression of LacD.1

HSC5

pJL156

Primers for expression of LacD.2

HSC5

pJL132

Primers for pET24d/LacD.1

HSC5

pJL134

Primers for pET24d/LacD.2

pJL75

pJL162

Primers for first half of LacD.12A for expression

pJL126

pJL162

Primers for second half of LacD.12A for expression

pJL162

pZC15

Primers for pET24d/LacD.12A

HSC5

pZC53

Primers for first half of pET24d/LacD.12B

HSC5

pZC53

Primers for second half of pET24d/LacD.12B

HSC5

pZC54

First half of pET24d/LacD.12C

HSC5

pZC54

Second half of pET24d/LacD.12C

pJL132

pZC43

Mutagenesis primers for LacD.1 (A265E A266S)

pZC43

pZC79

Mutagenesis primers for LacD.1L1 (A265E A266S Q269K
S271N)

pJL132

pZC41

Mutagenesis primers for LacD.1 (P285K)

pZC41

pZC76

Mutagenesis primers for LacD.1 (P285K E292P D293Q
E294A)

pZC76

pZC80

Mutagenesis primers for LacD.1T2 (P285K E292P D293Q
E294A T289E K290E)

pZC79

pZC88

Mutagenesis primers for LacD.1L1+T2 (A265E A266S Q269K
S271N, E292P, D293Q, E294A)

pZC88

pZC91

Mutagenesis primers for LacD.1L1+T2 (A265E A266S Q269K
S271N, E292P, D293Q, E294A, P285K)

pZC91

pZC99

Mutagenesis primers for LacD.1L1+T2 (A265E A266S Q269K
S271N, E292P, D293Q, E294A, P285K, T289E, K290E)

HSC5

pZC64

First half of pET24d/LacD.21F

HSC5

pZC64

Second half of pET24d/LacD.21F

pJL134

pZC81

Mutagenesis primers for LacD..2L1+T2 (K271Q N273S)

pZC81

pZC87

Mutagenesis primers for LacD..2L1+T2 (K271Q, N273S, P294E,
Q295D,A296E )

pZC87

pZC97

Mutagenesis primers for LacD..2L1+T2 (K271Q, N273S, P294E,
Q295D,A296E, K287P )

pZC97

pZC116

Mutagenesis primers for LacD..2L1+T2 (K271Q, N273S, P294E,
Q295D,A296E, K287P, E291T, E292K )

pJL126

pJL164

Primers for expression of LacD.21K

pJL75

pJL164

Primers for expression of LacD.21K

a. Engineered restriction sites are underlined. Sequence for Influenza hemagglutanin (HA) epitope tag is in italics
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Name

Sequencea

JLP167

GAGGCCATGGAAATGACAATTACTTTAAC

ZC99

/5PHOS/GCCTGCACTCAAATAGATAT

ZC100

/5PHOS/GTTTCTGCCAAATTGTTCCA

JLP168

AATACTCGAGCATTTTTTCAGTCCAAGG

ZC473

TTGAATTCTATCAATCTATTAAAGTCAAAGAGGTATAAAAAATGACAATTACTTTAACTGAAAACAAACG

ZC402

GTAAATTGATTTGTTCATCTCCATCAATATCATAGTAAAGAAGGAATTTAACTGCTTC

ZC403

GATGGAGATGAACAATCAATTTAC

ZC399

CTGCTGCAAATTCCAAAGTATCTTGAAAAAGTTTGGCAGATAC

ZC473

TTGAATTCTATCAATCTATTAAAGTCAAAGAGGTATAAAAAATGACAATTACTTTAACTGAAAACAAACG

ZC399

CTGCTGCAAATTCCAAAGTATCTTGAAAAAGTTTGGCAGATAC

ZC400

ACTTTCGAATTTGCAGCAG

ZC401

TGATCTGCAGTTAAGCGTAATCTGGAACATCGTATGGGTACATTTTTTCAGTCCAAGGACTTGC

ZC473

TTGAATTCTATCAATCTATTAAAGTCAAAGAGGTATAAAAAATGACAATTACTTTAACTGAAAACAAACG

ZC401

TGATCTGCAGTTAAGCGTAATCTGGAACATCGTATGGGTACATTTTTTCAGTCCAAGGACTTGC

ZC473

TTGAATTCTATCAATCTATTAAAGTCAAAGAGGTATAAAAAATGACAATTACTTTAACTGAAAACAAACG

ZC397

GTTTTTTCGTAAGCTAACAGTAAGCCTGCTTCTTCTGAACGAACACG

ZC398

GGCTTACTGTTAGCTTACGAAAAAAC

ZC399

CTGCTGCAAATTCCAAAGTATCTTGAAAAAGTTTGGCAGATAC

ZC473

TTGAATTCTATCAATCTATTAAAGTCAAAGAGGTATAAAAAATGACAATTACTTTAACTGAAAACAAACG

ZC399

CTGCTGCAAATTCCAAAGTATCTTGAAAAAGTTTGGCAGATAC

ZC473

TTGAATTCTATCAATCTATTAAAGTCAAAGAGGTATAAAAAATGACAATTACTTTAACTGAAAACAAACG

ZC401

TGATCTGCAGTTAAGCGTAATCTGGAACATCGTATGGGTACATTTTTTCAGTCCAAGGACTTGC

ZC259

TTTGAATTCGTAAGAGAGGTATCACATGACAATCACAGCAAATAAAAGACATTACCTAG

ZC423

CACGACTTGCTGGCAAGCCATATTCTGGATCTAATAAAATAGATGAAGC

ZC424

GGCTTGCCAGCAAGTCGTG

ZC401

TGATCTGCAGTTAAGCGTAATCTGGAACATCGTATGGGTACATTTTTTCAGTCCAAGGACTTGC

ZC259

TTTGAATTCGTAAGAGAGGTATCACATGACAATCACAGCAAATAAAAGACATTACCTAG

ZC401

TGATCTGCAGTTAAGCGTAATCTGGAACATCGTATGGGTACATTTTTTCAGTCCAAGGACTTGC

ZC259

TTTGAATTCGTAAGAGAGGTATCACATGACAATCACAGCAAATAAAAGACATTACCTAG

ZC401

TGATCTGCAGTTAAGCGTAATCTGGAACATCGTATGGGTACATTTTTTCAGTCCAAGGACTTGC

ZC259

TTTGAATTCGTAAGAGAGGTATCACATGACAATCACAGCAAATAAAAGACATTACCTAG

ZC401

TGATCTGCAGTTAAGCGTAATCTGGAACATCGTATGGGTACATTTTTTCAGTCCAAGGACTTGC

ZC259

TTTGAATTCGTAAGAGAGGTATCACATGACAATCACAGCAAATAAAAGACATTACCTAG

ZC260

ATCACACTGCAGTTAAGCATAATCTGGAACATCATATGGATAGATTTTTTCCGTCCAAGG

ZC259

TTTGAATTCGTAAGAGAGGTATCACATGACAATCACAGCAAATAAAAGACATTACCTAG

ZC260

ATCACACTGCAGTTAAGCATAATCTGGAACATCATATGGATAGATTTTTTCCGTCCAAGG

ZC259

TTTGAATTCGTAAGAGAGGTATCACATGACAATCACAGCAAATAAAAGACATTACCTAG

ZC260

ATCACACTGCAGTTAAGCATAATCTGGAACATCATATGGATAGATTTTTTCCGTCCAAGG

Template

Plasmid

pJL164

pZC55

pJL164

pZC55

HSC5

PCR 1

HSC5

PCR 2

Primers for construction of LacD.21H

PCR 1
+
PCR 2

PCR 3

Primers for construction of LacD.21H

HSC5

PCR 4

Primers for construction of LacD.21H

PCR 3
+
PCR 4

pZC209

Primers for expression of LacD.21H

HSC5

PCR 5

Primers for construction of LacD.21I

HSC5

PCR 6

Primers for construction of LacD.21I

PCR 5
+
PCR 6

PCR 7

Primers for construction of LacD.21I

PCR 7
+
PCR 4

pZC210

Primers for expression of LacD.21I

HSC5

PCR 8

Primers for construction of LacD.12J

pZC55

PCR 9

Primers for construction of LacD.12J

PCR 8
+
PCR 9

pZC211

Primers for expression of LacD.12J

pZC53

pZC206

Primers for expression of LacD.12B

pZC54

pZC207

Primers for expression of LacD.12C

pZC79

pZC127

Primers for expression of LacD.12(L1)

pZC80

pZC128

Primers for expression of LacD.12(T2)

pZC99

pZC129

Primers for expression of LacD.12(L1+T2)

a. Engineered restriction sites are underlined. Sequence for Influenza hemagglutanin (HA) epitope tag is in italics
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Description

Primers for first half of pET24d/LacD.21G for expression

Primers for second half of pET24d/LacD.21G for expression

Primers for construction of LacD.21H

!
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MATERIALS AND METHODS
Strains, media and growth conditions. Molecular cloning experiments utilized
Escherichia coli TOP10 (Invitrogen) and BL21 (DE3) was used for expression of
recombinant proteins. Experiments with S. pyogenes used strains HSC5 (12) and JL151
(26), a "LacD.1 derivative of HSC5 with an in-frame deletion in lacD.1 (SPy_1704).
Culture for all assays of function was at 37oC in C medium (29). In selected experiments,
C-medium was buffered by the addition of 1 M HEPES pH 7.5 to a final concentration of
0.1 M. Routine culture of S. pyogenes and E. coli utilized Todd Hewitt Yeast Extract
medium under anaerobic conditions and Luria-Bertani medium aerobically, respectively.
When appropriate, antibiotics were added to media at the following concentrations:
chloramphenicol, 15 µg/mL for E. coli and 3 µg/mL for S. pyogenes and kanamycin, 50
µg/mL for E .coli and 500 µg/mL for S. pyogenes.
Purification of enzymes. Proteins were expressed in BL21 DE2 cells as described
previously (26). Following expression, cells were collected by centrifugation and
disrupted by sonication(26).

The six-His-tagged proteins were purified by

chromatography over a cobalt affinity resin, according to the recommendations of the
manufacturer (Clontech). Eluted proteins were then dialyzed against a buffer consisting
of 50 mM NaPO4 (pH 7.5), 300 mM NaCl, and 25 mM !ME and further purified by gel
filtration chromatography using Superdex 200 10/300 GL (GE Healthcare). Fractions
containing purified protein were identified by SDS PAGE, were pooled and then dialyzed
against a buffer consisting of 50 mM NaPO4 (pH 7.5), 300 mM NaCl, 1 mM DTT in a
final volume of 25% glycerol and stored at -20°C.

Protein concentrations were

determined by absorbance at 280 nm of aliquots diluted into 6M Guanidine hydrochloride
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and final values calculated from the average of three different dilutions. Calculation of
protein extinction coefficients utilized ProtParam (http://web.expasy.org/ protparam/) (9).
DNA and computational techniques. Plasmid purification and transformation of E.
coli and S. pyogenes were performed as described previously (5, 22). The genes encoding
various LacD chimeric enzymes were constructed using the PCR products generated
using 5’ phophorylated primers for three-way ligations, or through a process of overlap
extension PCR (16). Restriction enzymes and additional reagents were used according to
the manufacturer’s recommendations (New England Biolabs). Site-directed mutagenesis
was performed by PCR followed by DpnI digestion of template using a commercial kit
(QuikChange Site-Directed Mutagenesis kit, Stratagene) and the primers and templates
described in Supplementary Table 1. The fidelity of all constructs was confirmed by
determination of DNA sequences using the services of a commercial vendor (SeqWright,
Houston, TX). Coordinates for protein structures were obtained from the Protein Data
Bank (www.pdb.org) and were compared using the PyMOL Molecular Graphics System
(Version 1.5.0.4, Schrödinger, LLC).
Aldolase cleavage assay and determination of steady state kinetic constants.
Aldolase activity was measured using a standard enzyme coupled assay that monitored
oxidation of !-NADH by following the decrease in absorbance at 340 nm in the presence
of the coupling enzymes glycerol-3-phosphate dehydrogenase and triosephosphate
isomerase (4). Enzyme was diluted to 100-170 nM into a reaction mixture consisting of
50 mM HEPES pH 7.5, 100 mM NaCl, 2.5 units glycerol-3-phosphate dehydrogenase, 20
units triosephosphate isomerase, and 0.25 mM !-NADH. The initial velocity (V0) was
plotted at varying concentrations of substrate ([S]) and fit to a standard equation (V0 =
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Vmax[S]/Km + [S]) to determine the Michaelis-Menten constant (Km) and the Vmax. The
kcat was calculated by dividing the Vmax by the enzyme concentration. For cleavage of
FBP at pH 7.5, a substrate range of 0.2-8 mM was used for LacD.2 and 0.2-40 mM used
for LacD.1. For cleavage of TBP at pH 7.5 (supplied by Dr. Wolf-Dieter Fessner of
Technische Universität, Darmstadt, Germany), a substrate range of 0.1-2 mM was used
for LacD.2 and 0.5-16 mM used for LacD.1. For cleavage of FBP at pH 6.8, a substrate
range of 0.2-8 mM was used for all enzymes. For cleavage of TBP at pH 6.8, a substrate
range of 0.04-4 mM was used for all enzymes.
Influence of pH on aldolase activity. The aldolase cleavage assay was performed as
described above in reaction mixture buffered by 50 mM BisTris (pH range 6.0 - 6.5) or
by 50 mM HEPES (pH range 6.8 – 8.0). The kcat /Km was calculated and fit to the
equation log Y = log(C/(1+[H]/Ka + Kb/[H] + [H]2 /KaKb)) using Graphpad Prism
(Version 5, GraphPad Software, San Diego, CA).
Determination of molecular weight. Purified protein and molecular weight standards
(GE Healthcare) were either dialyzed against or resuspended in a buffer of 50 mM
NaPO4, 300 mM NaCl, and 25 mM !ME. Aliquots ranging from 100-200 µLs were then
developed over a Superdex 200 HR 10/300 GL column with a flow rate of 0.5 mL/min.
Elution of protein was monitored by absorbance at 280 nm. The value of Kav was
calculated for each standard using the equation Kav = (Ve – Vo)/(Vt – Vo), where Ve is the
elution volume, Vo is the void volume (8.107 mL), and Vt is the bed volume (24 mL).
For each standard, the Kav was plotted against the log Mr (molecular weight). The
calculated molecular weight of LacD.1 and LacD.2 represents the average of at least
three separate experiments.
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Influence of aldolase concentration on activity. To determine the enzymatic activity
of LacD.1 and LacD.2, an aliquot of 5 µL containing enzyme at concentrations ranging
from 100 nM to 5 mM was added to 95 µLs of a mixture containing 50 mM HEPES, pH
7.5, 100 mM NaCl, 15 units GDH, 600 units TIM, 22.5 mM FBP and 250 or 500 µM of
!-NADH. The measured rate of decrease in absorbance at 340 nm was used to calculate
the activity at each concentration of enzyme. The slope of enzyme activity plotted versus
enzyme concentration is equal to the specific activity of each aldolase and was
comparable to the specific activity calculated from the kcat of each enzyme determined
from steady state experiments.
SpeB Protease Activity. Protease activity was measured as described previously by
spotting a 5 µL aliquot of an overnight bacterial culture from each strain under analysis
onto the surface of solidified unmodified or modified C medium supplemented with 2%
milk (29). Following overnight culture under anaerobic conditions, protease activity was
apparent as a zone of clearing surrounding the bacterial growth. Quantitative analysis of
protease activity following overnight culture in liquid medium was determined using a
fluorescein isothio-cyanate casein substrate as described (26).
Determination of Fitness.

Overnight cultures in C-medium supplemented with

choloramphenicol of the strains indicated in the text were back-diluted 1:100 into fresh
C-medium with chloramphenicaol and incubated for approximately 4 hrs.

Culture

densities were normalized by OD600 and co-cultures established by co-inoculation of 50
µL of both test and competitor strains into 10 ml of C-medium containing
chloramphenicol. Following overnight incubation, each culture was back-diluted 1:1000
in fresh medium and this process was continued for 4 days. The competitor strain was
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"LacD.1 complemented with pLacD.1-kan, a plasmid identical to pLacD.1 except for
removal of the kanamycin resistance cassette.

The test strains were "LacD.1

complemented with the various plasmids indicated in the text. Cultures were grown in
the presence of chloramphenicol, as both test and competitor plasmids carry an identical
chloramphenicol resistance cassette. Growth rates were calculated for each individual
strain in the absence of competition to confirm that these were identical. To enumerate
CFUs, serial dilutions from cultures were plated on Todd Hewitt Yeast Extract media
with and without kanamycin at the indicated time points. Data shown are the average of
at least 2 independent experiments.
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Chapter III
Contribution of Arginine and Citrulline Catabolism to Streptococcus pyogenes
pathogenesis

SUMMARY
The ability of a bacterium to acquire nutrients from a host during an infection is
essential for colonization and thus pathogenesis. For the pathogen Streptococcus
pyogenes, the catabolic, arginine deiminase (ADI) pathway has been shown to be upregulated in a mouse model of a soft tissue infection, suggesting that this pathway
contributes to S. pyogenes’ metabolism during an infection. Typically arginine catabolism
in bacteria aids in the supplementation of energy and protects against acid stress through
the production of ATP and ammonia, respectively. To investigate the role of arginine
catabolism in the pathogenesis of S. pyogenes we utilized a subcutaneous mouse model of
infection. In-frame deletions of enzymes through out the pathway revealed the inability
to utilize arginine resulted in a disruption in pathogenesis. Further analysis demonstrated
mutants unable to utilize arginine or citrulline were hyper attenuated, suggesting an
important role for citrulline utilization in S. pyogenes pathogenesis. Additionally,
infection of iNOS knock out mice with a mutant in the ADI pathway produced wild type
lesions, suggesting a role for arginine catabolism in the inhibition of the inducible nitric
oxide synthase (iNOS) through substrate depletion. Together this work demonstrates the
importance of arginine and citrulline catabolism in an infection, and suggests a novel
mechanism by which S. pyogenes modulates the innate immune response by limiting the
production of the antimicrobial, nitric oxide.
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INTRODUCTION
Nutrient acquisition by a pathogen is necessary for the colonization of a host, and
is therefore an important aspect of bacterial pathogenesis. Identification of bacterial
metabolic pathways utilized during an infection can provide unique targets for novel
therapeutics, as well as provide insight into the environmental cues being sensed by the
pathogen. Additionally, the metabolism of a microbe, shuttling key metabolites away
from or toward the host, can contribute to how the host responds to a pathogen. The
difficulty then becomes identifying the role of metabolic pathways active during an
infection and deciphering their specific contribution to pathogenesis.
Streptococcus pyogenes (group A streptococcus) is a common Gram positive
pathogen responsible for a large number of diseases that range in severity and
invasiveness (12). The more common, non-invasive infections include bacterial
pharyngitis and impetigo, while less common infections include the invasive and often
life threatening, necrotizing fasciitis (12)%!!Research examining the nutrients available to
S. pyogenes during an infection has revealed that the environment encountered is likely
deficient in glucose with an abundance of amino acids and peptides (35). This nitrogen
rich environment encountered by the bacteria results in the up-regulation of amino acid
and peptide transporters, as well as peptidases that likely aid in providing the cellular
energy necessary for replication (26, 27). One metabolic operon that was found to be upregulated in a soft tissue infection in a mouse model and in human blood was the arginine
deiminase pathway (26, 27).
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The arginine deiminase (ADI) pathway, encoded by the Arc operon in S.
pyogenes, is involved in a number of aspects of bacterial metabolism including the
production of cellular energy and the protection against acid stress (1, 11). The ADI
pathway is composed of three key enzymes: ArcA, ArcB, and ArcC, and an antiporter,
ArcD(2, 36, 50) (Figure 1). The first enzyme in the pathway is ArcA, an arginine
deiminase, involved in the liberation of an ammonia group from arginine to produce
citrulline. Next, the ornithine carbamoyl transferase, ArcB, cleaves citrulline to produce
ornithine and carbamoyl phosphate, the latter being utilized by ArcC to form a molecule
of ATP, carbon dioxide, and ammonia (2, 3, 14, 17, 28, 29, 36, 48, 50). The byproduct of
ArcB’s reaction, ornithine, is then utilized by ArcD in an ATP independent manner to
transport ornithine out, and concomitantly bring arginine into the cell (18).
Interestingly, carbamoyl phosphate is also a precursor in pyridine biosynthesis,
suggesting a possible contribution of arginine catabolism to the production of prymidines.
In addition to generating ATP, this pathway also aids in protection against acid
stress (11, 38). The production of two ammonia molecules can be utilized to buffer
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against the decrease in pH, often associated with the production of lactic acid, a
byproduct of fermentation (49). Disruption of this pathway in S. pyogenes results in an
increase in susceptibility to acid stress (16). Given the ability of this pathway to
contribute to both ATP production as well as protect against acid stress, it is not
surprising that arginine catabolism has been found to play a key role in the pathogenesis
of a number of bacterial species (31, 47). Indeed, in addition to contributing to the
bacteria’s metabolism, arginine utilization in vivo can also greatly influence how the host
responds to a pathogen (15).
Upon detection of a pathogen, immune cells including neutrophils and
macrophages are recruited to the site of infection in an attempt to contain the bacteria.
To do so, they enlist a number of bactericidal mechanisms, including the production of
nitric oxide (NO) by inducible nitric oxide synthase (iNOS) (41). This enzyme is
typically expressed by macrophages and utilizes arginine to produce NO and citrulline.
Given the requirement for arginine, iNOS is often directly regulated by the availability of
this extracellular substrate (40, 42). This link of NO production to arginine availability
has resulted in a number of examples where microbes attempt to regulate the production
of the toxic molecule, NO, by limiting arginine availability (6, 15). Identification of the
role of macrophage recruitment to an S. pyogenes infection has established macrophages
as an important mediator for clearance and controlling dissemination of bacteria,
suggesting a likely role of iNOS and NO in this process (24, 39).
To investigate the role of arginine catabolism in S. pyogenes pathogenesis we
began by making an in-frame deletion in the first enzyme in the pathway, ArcA, and
monitoring the influence on pathogenesis in our subcutaneous mouse model of infection.
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Our results demonstrate that arginine catabolism does contribute to pathogenesis as
demonstrated by a decrease in lesion size, as well as a reduction in bacterial colony
forming units. Further investigation into the contribution of this pathway revealed that
deletion of ArcB or ArcC resulted in significantly smaller lesions compared to both wild
type bacteria, as well as the ArcA mutant. This decrease in lesion size and bacterial
burden was found to be associated with the ability to utilize both arginine and citrulline in
vitro. Furthermore, infection of an iNOS knock out mouse with a !ArcA mutant
revealed an increase in lesion size comparable to a wild type infection, suggesting a
unique contribution of arginine catabolism in S. pyogenes to the modulation of the host
innate immune response.
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RESULTS
An ArcA mutant is attenuated in a subcutaneous mouse model of infection.
To investigate the role of arginine catabolism in the pathogenesis of S. pyogenes, we
began by making an in-frame deletion in the first
enzyme in the pathway, ArcA. Following
deletion of arcA, the generated mutant was
assayed for the ability to catabolize arginine by
measuring growth in C-medium supplemented
with 10 mM arginine. For wild type cells, the
addition of 10 mM arginine to C-medium results
in an increase in cellular density, as measured by
OD600 (Figure 2). However, with !ArcA there was no increase in the OD600 in the
presence of 10 mM arginine, confirming that the Arc operon encodes a functional ADI
pathway capable of utilizing arginine as an energy source (Figure 2).! Following this in
vitro characterization, we next wished to
investigate the role of arginine catabolism in
our mouse subcutaneous infection model.
Subcutaneous infection of S. pyogenes in a
mouse typically results in the formation of a
lesion after twenty-four hours with the lesion
growing in size and peaking on day three.
Monitoring the lesion size formed by both
wild type and the arcA mutant bacteria
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revealed that for the five-day period examined, the arcA mutant formed significantly
smaller lesions compared to wild type on all days measured (Figure 3). This data
demonstrates the importance of arginine catabolism in vivo and suggests that arginine is
an important energy source encountered by S. pyogenes during an infection.
Deletion of ArcB and ArcC result in significantly smaller lesions compared to an
ArcA mutant.
Arginine catabolism can contribute to bacterial metabolism and pathogenesis in a
number of different ways, including the production of ATP, carbamoyl phosphate, and
the inhibition of iNOS. To determine the specific contributions of arginine catabolism on
S. pyogenes pathogenesis, we decided to make in-frame deletions in arcB, arcC, and
arcD. By comparing each mutant to !ArcA we hoped to be able to dissect arginine
catabolism’s contribution to an S. pyogenes infection. Initial in vitro characterization of
all three arc mutants revealed a disruption in the ability to catabolize arginine comparable
to an arcA mutant, as determined by growth in C-medium supplemented with 10 mM
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arginine (Figure 2). These results confirm the requirement of all four proteins for a fully
functioning ADI pathway. Following in vitro characterization, the in vivo contribution of
all three mutants was analyzed in our mouse model of infection. Comparison of lesion
sizes on day three revealed two distinct phenotypes compared to wild type bacteria
(Figure 4). The first phenotype, including the mutants !ArcA and !ArcD, consisted of
lesions significantly smaller than the wild type strain (Figure 4). The second phenotype,
included the mutants !ArcB and !ArcC, and was hyper attenuated, forming significantly
smaller lesions compared to !ArcA (Figure 4). Given that these enzymes function in a
distinct metabolic pathway, we had hypothesized that deletion of genes downstream of
ArcA would either phenocopy an arcA mutant or behave similar to our wild type strain,
however this was not what was observed.
One proposed explanation for this phenotype is the build up of intermediates in
!ArcB and !ArcC strains that are either detrimental to the bacteria or beneficial to the
host. To test this hypothesis, we repeated our subcutaneous infection with wild type
bacteria, the two single mutants !ArcA and !ArcB, and a double mutant !ArcA !ArcB.
Deletion of arcA in a !ArcB background should prevent production of any detrimental
intermediates and alleviate their influence. In addition to measuring lesion size on day 3,
we also harvested the lesions and plated them for CFUs. Bacterial CFUs recovered from
a !ArcA infection was significantly lower compared to wild type (Figure 5B), but
remained significantly higher than the bacteria recovered from a !ArcB infection,
confirming the phenotype observed previously (Figure 5B). Analysis of the infection with
the double mutant resulted in significantly smaller lesions on day three compared to
!ArcA as well as a reduction in recoverable bacterial CFUs (Figure 5). These results
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suggest that the attenuation in vivo seen for !ArcB and !ArcC are due to the lack of a
functional ArcB or ArcC enzyme, respectively, and not due to the build up of
intermediates in the Arc pathway. Given that ArcB functions downstream of ArcA on
the amino acid citrulline, the resulting decrease in lesion size associated with an arcB and
arcC mutant can likely be attributed to the inability to utilize both arginine and citrulline.

An arcA mutant can utilize citrulline in vitro but an arcB or arcC mutant cannot.
To test whether S. pyogenes could utilize citrulline as an energy source, the
growth of bacteria in medium supplemented with 10 mM citrulline was monitored by
OD600. Growth of wild type bacteria or any arc mutant revealed no increase in OD over
time compared to unmodified medium, suggesting cellular density could not be increased
through the utilization of citrulline (data not shown). Previous research involving arginine
catabolism in S. pyogenes has demonstrated the utilization of citrulline to protect against
acid stress (16). To confirm these results and further investigate the influence of our
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mutants on citrulline utilization, we monitored the ability of both arginine and citrulline
catabolism to protect S. pyogenes against acid stress.
Protection from acid stress was measured by growing the bacteria in a rich
medium, ThyB, containing a high concentration of glucose. As a consequence of
fermentation the pH of the medium is rapidly acidified. This acidification has been
determined to be lethal to S. pyogenes and ultimately results in a decrease in bacterial
CFUs that can be monitored over time, with no detectable bacteria remaining by day six.
Bacteria cultured in C-medium buffered to pH 7.5 remained viable throughout day six
suggesting the loss of bacterial viability is associated with a decrease in the medium’s pH
(data not shown). For wild type bacteria, addition of 10 mM arginine or 10 mM citrulline
both mitigated the decrease in viability with roughly 106 and 105 bacteria still being
detected on day six, respectively. Following six days of growth, the medium in which the
bacteria grew was collected, filter sterilized and the pH measured. Comparison of the
medium pH for wild type bacteria containing arginine or citrulline revealed a significant
increase in pH due to the production of ammonia, thus confirming utilization of both
substrates (Figure 7). This result revealed that despite being unable to increase the
cellular density of a culture, utilization of citrulline did protect the bacteria from acid
stress.!!Comparison of an arcA mutant to wild type reveals a more rapid drop off in CFUs
over time as well as no increase in viability in the presence of arginine (Figure 6).
However, the addition of 10 mM citrulline was able to protect the mutant through the sixday time course (Figure 6), confirming the ability of this mutant to utilize citrulline.
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Measurement of the final pH of !ArcA medium containing citrulline did not reveal as
large of an increase in pH as wild type (Figure 7), likely due to the inability to utilize
additional arginine already present in the unmodified medium. Analysis of the arcB or
arcC mutant’s ability to withstand the acid stress in medium supplemented with arginine
or citrulline revealed that they were both defective in protecting against the acid stress
regardless of the supplemented amino acid (Figure 6). However surprisingly the arcD
mutant was able to survive in both the presence of arginine and citrulline (Figure 6)
suggesting a redundancy in the transport of arginine and perhaps citrulline. However,
given that !ArcD cannot utilize arginine for growth, this redundant transport of arginine
is not sufficient for utilization as an energy source. This insufficiency could be due to a
lower affinity for arginine directly or a reduced expression compared to ArcD.!!
Utilization of citrulline
by S. pyogenes to protect
against acid stress has been
previously reported and is
confirmed here. Disruption of
the ability to utilize both
arginine and citrulline
correlates with the formation of
significantly smaller lesions
during an infection, suggesting utilization of both amino acids in vivo is crucial for
pathogenesis. Furthermore, deletion of arcD did not disrupt the ability of S. pyogenes to
utilize arginine or citrulline for protection against acid stress (Figure 6), suggesting
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redundant mechanisms of transport for these amino acids. Additionally, analysis of the
medium pH after six days revealed that survival by !ArcA or !ArcD in the presence of
citrulline or arginine, respectively, did not correlate with a significant increase in
extracellular pH (Figure 7), which may indicate a role of ATP production in protection
against acid stress.
RAW264.7 Macrophages up-regulate iNOS during an infection with S. pyogenes
Identification of the role of arginine catabolism in S. pyogenes pathogenesis
suggested that during infection arginine is a viable energy source and likely rapidly
catabolized. This catabolism of arginine, while important for bacteria’s energy
production and protection from acid stress, can also greatly influence the host,
specifically immune cells targeted to the site of an infection. Macrophages are often
recruited to an active infection, and have been demonstrated to be essential for
controlling dissemination of S. pyogenes. Upon arrival, macrophages can target bacteria
through a number of different bactericidal effectors including NO. To begin to address
the influence of bacterial arginine catabolism on the host’s ability to produce NO, we first
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looked to see if the enzyme iNOS was up-regulated in macrophages during an infection
with S. pyogenes. To augment the production of nitric oxide, INF", which has been
shown to be important for protection against S. pyogenes infections (43), was added to
the macrophages 24 hours prior to the addition of bacteria. Following infection with S.
pyogenes at varying MOIs, the RNA from macrophages was purified and the transcript
levels of iNOS quantified using real-time RT-PCR. Analysis of transcripts levels
revealed that with increasing MOI, the mRNA levels of iNOS increased proportionately
in a dose dependent manner, with the highest MOI of 10 producing levels of transcript
comparable to the positive control, LPS (1mg/mL) (Figure 8A). Furthermore, production
of NO by macrophages can be indirectly measured using Griess reagent, and was found
to be produced to levels similar to LPS, thus demonstrating the induction of iNOS
transcription and production of NO by macrophages in the presence of S. pyogenes
(Figure 8B).
An ArcA mutant forms wild type lesion in an iNOS knock out mouse.
Given the induction of iNOS and the production of NO by macrophages in the
presence of S. pyogenes, we next examined if arginine utilization by the bacteria in vivo
was actively inhibiting NO production through substrate depletion.
To test this hypothesis infection in C57BL/6 mice lacking a functional iNOS was
compared to infection in a wild type mouse strain with the same genetic background.
Both mouse strains were infected with either HSC5 (wild type), !ArcA, or !ArcB
followed by measurement of lesions and enumeration of bacterial CFUs on Day 3.
Comparison of infection in the wild type or iNOS knock out (KO) mice revealed that
with either HSC5 (wild type) or !ArcB, no significant difference was observed in lesion
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area or bacterial CFUs. Conversely, infection of iNOS KO mice with !ArcA resulted in
significantly larger lesions compared to those produced by !ArcA in wild type mice. In
addition, the bacterial burden was significantly greater in iNOS KO mice compared to
wild type. This data suggests that that during an infection ArcA functions to inhibit NO
production through substrate depletion. In the instance when this activity is abolished by
deletion of arcA, the host enzyme iNOS is unabated in its production of NO, resulting in
the killing of S. pyogenes. Additionally this work demonstrates that attenuation of
virulence seen with a !ArcB mutant is not due to an increase in NO production, but
rather due to the disruption of citrulline catabolism. Taken together this data confirms
the role of arginine catabolism in modulation of host response and further supports the
important contribution of citrulline catabolism in S. pyogenes pathogenesis.
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DISCUSSION
In the present study we looked to examine the contribution of arginine catabolism
to S. pyogenes pathogenesis. Through a series of in-frame deletions we were able to
determine that the utilization of both arginine, as well as citrulline contribute to bacterial
survival during an infection. Additionally, infection of iNOS KO mice with wild type
and an arcA mutant revealed the novel contribution of arginine catabolism to the
inhibition of NO production by iNOS, demonstrating a unique role of arginine catabolism
in the modulation of the host innate immune response. Together this work highlights the
influence a pathogen’s metabolism can have on both the bacteria and host during an
infection.
Utilization of arginine can aid in both the production of ATP, as well as through
protection against acid stress. Given that these two contributions occur simultaneously it
is difficult to determine, which is required during an infection. In an attempt to segregate
the influence of arginine catabolism on pathogenesis, in-frame deletions in enzymes
through out the ADI pathway were examined. Interestingly, in vitro analysis of these
mutants revealed the requirement for both ArcB and ArcC in survival against acid stress.
Indeed, analysis of the arcC mutant revealed that despite maintaining a medium pH equal
to or higher than the arcA mutant in ThyB supplemented with citrulline, it was unable to
survive to similar levels. Previous research has suggested production of ATP is
necessary for protection against acid stress, which may explain this phenotype (10). To
confirm this hypothesis, a closer examination of the intracellular pH of the bacteria under
these conditions, as well as investigation into the in vivo environment encountered, will
be required to determine the exact role of the ADI pathway in pathogenesis.
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Another interesting insight from this work came from the discovery of citrulline
utilization by S. pyogenes during an infection. Citrulline is a non-essential amino acid
that is not incorporated into proteins, and until recently has only been thought of as a
metabolic intermediate in the urea cycle (44). Citrulline production can occur by the
enzyme iNOS, as described above, or through the conversion of ornithine by the host
enzyme ornithine carbamoyl transferase (45). Recent investigation into arginine-citrulline
conversion has revealed a possible role of citrulline in fine-tuning arginine homeostasis in
response to diet (13). Given this flux of nitrogen between arginine and citrulline, it is not
surprising that both amino acids present themselves as viable nutrient sources for S.
pyogenes and other pathogens during an infection.
Recently, utilization of citrulline by Francisella tularensis has also been shown to
contribute to pathogenesis (37). F. tularensis is a Gram negative pathogen, and the
causative agent of tularemia. In F. tularensis, catabolism of citrulline occurs via the
enzyme citrulline ureidase, a hydrolase enzyme involved in cleaving citrulline to produce
ornithine and ammonia (20). Production of ammonia by F. tularensis in the endosomal
compartment of macrophages is believed to inhibit phagosomal maturation, thus
protecting the bacteria (34). Additionally, this enzyme has recently been proposed to
inhibit NO production by macrophages through depletion of citrulline (37).
Citrulline conversion back into arginine occurs through the enzymes
arginosuccinate synthase (ASS) and arginosuccinate lyase (ASL) (13). These enzymes
function in macrophages to recycle citrulline into arginine, keeping a steady supply
available for iNOS (7). Indeed, up-regulation of ASS gene expression by proinflammatory cytokines demonstrates the shift in arginine availability required to combat
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an infection (4). Thus utilization of citrulline by a pathogen could possibly aid in an
infection by limiting the supply of arginine, as believed to be the case with F. tularensis
(37). In contrast, in the present study deletion of the enzyme ArcB resulted in a drastic
reduction in virulence in both the wild type and iNOS KO mice, suggesting the inability
to catabolize citrulline likely contributes to bacterial survival irrespective of NO
production. However, given the severe phenotype displayed by the arcB mutant, it is
possible that this mutant is refractory to changes in iNOS activity. Thus, the lack of a
phenotype may be misleading to what is actually occurring during the infection.
Alternatively, given that !ArcB still possesses a functional ArcA it is also plausible that
depletion of arginine by !ArcB in vivo is sufficient to inhibit the production of NO.
These conflicting theories raise many interesting questions regarding the utilization of
citrulline in vivo, and will require further investigation to answer.
In contrast to !ArcB, infection of iNOS KO mice with an arcA mutant resulted in
lesion sizes comparable to wild type bacteria, along with increased recovery of bacterial
CFUs. Demonstrating ArcA’s major contribution to virulence is through the inhibition of
iNOS. Inhibition of NO production has been demonstrated to occur in other pathogens
including Heliobacter pylori that depletes arginine availability with an encoded arginase,
RocF (22). The targeting of iNOS activity by such a range of pathogens highlights the
importance of this antimicrobial in the host innate immunity (15). Previous research
looking at macrophage activation during an S. pyogenes infection has suggested iNOS is
not up regulated in the presence of this bacterium (25). These experiments involved
intra-peritoneal infection of mice, followed by isolation of macrophages from the
peritoneal cavity at one, four, and 16 hours post infection. Analysis of the macrophages

!

((#!

transcriptome revealed iNOS was not up regulated under these conditions. However, both
the route of infection as well as the time at which the macrophages were examined can
explain these contradicting results. Variation in the environment in which an infection
occurs, as well as changes in the temporal expression of cytokines, will drastically
influence macrophage transcription. Previous research examining an intravenous
infection of S. pyogenes in mice demonstrated an increase in NO in serum during an
infection (23). This work further revealed a host genetic component of NO production as
illustrated by changes in the amount of NO produced in two different mouse strains (23).
Furthermore, recent experiments looking at the recruitment of macrophages into soft
tissue following infection have found that peak expression of the pro-inflammatory
cytokine, TNF#, does not occur until 48 hrs post infection (39). Additionally, this
research has also demonstrated an important contribution of macrophages to limiting the
dissemination of S. pyogenes, suggesting an alternative function of macrophages is
necessary for controlling an S. pyogenes infection. Continuing research into the role of
macrophages in a soft tissue infection, and examination of their activation profile over
time will be essential in elucidating their contribution to an S. pyogenes infection.
In addition to a reduction in NO production, inhibition of iNOS can have a large
influence on a macrophage’s response to a pathogen. Competition for arginine utilization
by iNOS can occur by both a pathogen and the host enzyme arginase. Several pathogens
including Salmonella have used this competition in their favor by inhibiting NO
production by iNOS through the activation of the host arginase (33). This up-regulation
of arginase results in a decrease in arginine availability as well as an increase in
downstream metabolites including ornithine, which is converted into polyamines such as
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spermidine and spermine. Spermine has been demonstrated to inhibit pro-inflammatory
gene expression increasing survival of the pathogen (9). This balance between iNOS and
arginase in the host raises interesting questions as to additional influences arginine
catabolism by S. pyogenes may have on an infection. Indeed, can increased production of
ornithine by S. pyogenes be funneled into the host to increase production of spermidine
and spermine, and how do these polycations influence the infection. Further
investigation into production of these metabolites as well as others involved in wound
healing will be essential in understanding the influence S. pyogenes’ metabolism has on
host-pathogen interactions and pathogenesis.
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MATERIALS AND METHODS
E. coli strains, media, and growth conditions. The E. coli strain DH5# was cultured in
Luria-Bertani medium at 37ºC and utilized for common molecular cloning techniques.
When appropriate antibiotics were added to the medium at the following concentrations:
erythromycin 750 µg/mL.

Streptococcus pyogenes strains, media, and growth conditions. Streptococcus
pyogenes HSC5(30) and mutant derivatives of this strain (Table 1) were utilized for these
experiments. Strains were grown in Todd-Hewitt Broth (THYB) (DIFCO) supplemented
with 0.2% Yeast Extract (DIFO). When indicated in text, strains were also grown in Cmedium (0.5% Protease Peptone #3 (DIFCO), 1.5% Yeast Extract (DIFCO), 10 mM
K2HPO4, 0.4 mM MgSO4, 17 mM NaCl). Supplementation of medium with arginine or
citrulline occurred after autoclaving medium and was prepared by adding from a 0.5 M
filter sterilized stock to a final concentration of 10 mM. In all media conditions growth of
indicated strains utilized sealed culture tubes at 37ºC under static conditions.
Streptococci grown on THYB medium solidified by the addition of 1.4% Bacto Agar
(DIFCO) were cultured anaerobically in sealed jars in the presence of commercially
available gas-generating packets (GasPak cat. #70304, BBL). When appropriate
antibiotics were added to the medium at the following concentrations: erythromycin 1
µg/mL.
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Construction of deletion mutants. All references to genomic loci are based upon the
genome of S. pyogenes SF370 (19). In-frame deletion mutations in genes encoding ArcA
(SPy_1547), ArcB (SPy_1544), ArcC (SPy_1541), and ArcD (Spy_1543) were generated
using allelic replacement as previously described(46). Construction of the individual
allelic replacement vectors utilized the vector pJRS233 (21) and were generated -./01!#2!
345.3456789:;<!36/=;6.!>56!:46;;?@97!8/19:/50.A!56!:465-14!9!365B;..!5>!5C;6893!
;D:;0./50!EFG!H+*I!!@/:4!:4;!/0</B9:;< primers listed in Table 2. Verification of the
allelic replacement was confirmed by PCR.

Acid stress assay. Indicated strains were grown in unmodified ThyB, ThyB
supplemented with 10 mM arginine, or 10 mM citrulline. At indicated time points the
culture was re-suspended and a small aliquot removed for serial dilution in PBS. The
bacteria were then plated on ThyB medium. Following overnight culture, the number of
CFUs on the plate were enumerated. At the end of six-day period the culture was
centrifuged and five mL of the medium removed and filter sterilized. The pH of the
medium was then measured using a pH probe (Accumet AB15 pH meter).

Subcutaneous infection of mice. As described previously infection of 6 to 8-week old
female SKH1 (Charles Rive Labs), C57BL/6 (cat. #000664), or B6.129P2-Nos2tm1Lau/J
(iNOS -/- cat. #002609) mice were infected subcutaneously with 107 bacterial CFUs of
each indicated strain (5, 8). Following infection the resulting ulcers were imaged on the
day noted in the text, and analyzed using the image software ImageJ
(http://rsb.info.nih.gov/ij/index.html) to determine the area of the irregular border of each
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lesion. The data presented are from at least two independent experiments with at least a
total 10 mice in each experimental group. Differences in lesion area were tested for
significance using the Mann-Whitney U-test. When noted in the text, recoverable CFUs
were measured by excision of the lesion and placement into 1 mL of sterile phosphatebuffered saline (PBS). The tissue was immediately homogenized using sterile
homogenizer probes until no detectable tissue fragments remained. Following
homogenization the resulting suspensions were serially diluted in PBS and plated on
THYB medium. Following overnight culture, the number of CFUs on the plate were
enumerated. Data displayed represents the pooling of least two independent experiments
with at least 10 mice per experimental group. The difference in CFUs between
experimental groups was tested for significance using the Mann-Whitney U-test.

Preparation of S. pyogenes for Macrophage infection. S. pyogenes was grown
overnight in THYB, diluted in fresh THYB and allowed to grow for approximately 34hrs to an OD600 of 0.2. The bacteria were then collected by centrifugation and washed
with 10 mLs of 0.9 % (Endotoxin-free) Saline solution (Teknova). Next the bacteria
were collected by centrifugation and suspended in 1 mL of 0.9 % Saline solution. The
cells were then sonicated on ice to disrupt chains and the number of bacterial cells
enumerated using a hemocytometer (Hausser Scientific Partnership cat # 3900). When
necessary the bacterial suspension was diluted in 0.9 % saline solution to the appropriate
density. Bacterial CFUs were determined by serially diluting the bacterial suspension in
PBS and plating on THYB medium, followed by enumeration of CFUs after overnight
growth.
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S. pyogenes infection of RAW264.7 Macrophages. The murine macrophage cell line
RAW 264.7 was plated in a six-well tissue culture plate (TPP) and maintained in RPMI1640 (Life Technologies) with 10% FBS in a humidified 5% CO2 atmosphere. Prior to
infection macrophages were washed with Dulbecco’s phosphate-buffered saline (DPBS)
(Life Technologies) and fresh medium added. An aliquot of the bacterial suspension was
added to each macrophage-containing well and incubated at 37ºC in 5 % CO2 for 30
minutes As a positive control LPS from E. coli (Sigma cat # L4391) was added to a well
at a final concentration of 1µg/mL. Following this incubation all the wells were washed
with 1-2 mL of DPBS followed by addition of fresh cell culture medium containing 100
units/mL of penicillin and 100 µg/mL streptomycin and allowed to incubate for an
additional four hours. Macrophages were harvested in 1 mL of DPBS using a cell scraper
and collected by centrifugation. The macrophage cell pellet was placed at -80ºC for
storage. Prior to collection of the cells by centrifugation a small aliquot was removed
and the macrophages counted with a hemocytometer (Hausser Scientific Partnership cat #
3200) to determine the total number of macrophages/well. For measurement of NO,
macrophages were prepared as above and plated in a twelve-well tissue culture plates
(TPP). Following a 60-minute infection with S. pyogenes or LPS (1µg/mL) the wells
were washed with DPBS and fresh medium containing 100 units/mL of penicillin and
100 µg/mL streptomycin was added. Macrophages were allowed to incubate for an
additional twenty-four hours, after which a small aliquot was removed and centrifuged at
high speed to remove any cells or cellular debris.
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Isolation of RNA and real-time RT-PCR. Total RNA was isolated from macrophages
using Qiagen QIAshredder and RNeasy Mini kit per the manufacturer’s protocol. RNA
was subjected to reverse transcription (RT) using iScript (Bio-Rad) per the
manufacturer’s instructions. RT-PCR analysis of cDNA samples was performed using iQ
SYBR green Supermix (Bio-Rad) using the primers listed in Table 2. Relative transcript
levels were determined using the !!Ct method using GAPDH transcript as a standard
followed by comparison to uninfected cells. Data presented are the means derived from
triplicate determinations of two separate samples prepared from at least two independent
experiments. Differences between the means of experimental groups were tested for
significance using Mann-Whitney U-test.

Measurement of NO Concentration. The concentration of byproducts formed by the
oxidation of NO, NO3- and NO2- were measured using the Griess reagent system
(Promega) per manufacturer’s instructions. Absolute concentrations were determined by
preparation of a standard curve in cell culture medium.
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CHAPTER IV
Regulation of the Arc operon in Streptococcus Pyogenes by the Transcriptional
Regulators ArcR and AhrC.2

SUMMARY
In Streptococcus pyogenes arginine utilization occurs via the arginine deiminase
pathway (ADI) encoded by the Arc operon. The utilization of arginine by the pathogenic
bacterium S. pyogenes has recently been determined to contribute to virulence during a
soft tissue infection. The importance of this metabolic pathway on pathogenesis suggests
investigation into the regulation of the Arc operon will provide valuable information
regarding the mechanism by which activation of transcription occurs, as well as insight
into the environmental signals being sensed by the bacteria during an infection. Here we
report, that in-frame deletion of either of the two putative transcriptional regulators arcR
or ahrC.2 resulted in disruption in the ability to catabolize arginine. Transcriptional
analysis of these mutants demonstrated a down regulation of the Arc operon in all phases
of growth, revealing a requirement for both arcR and ahrC.2 for expression of genes in
this operon. Furthermore, utilization of a biotinylated-DNA pulldown assay
demonstrated the specific binding of AhrC.2 to the promoter region of the Arc operon in
an ArcR-dependent manner, further supporting a role for both regulators in the
transcriptional control of this operon. Analysis of these mutants in our mouse model of
infection revealed that deletion of ahrC.2 resulted in significantly smaller lesions
compared to wild type, while deletion of arcR did not produce any significant phenotypic
change. Together this work demonstrates the importance of Arc operon regulation in S.
pyogenes, and raises interesting questions regarding the regulation of the Arc operon in
vivo, and the influence of these regulators on genes outside of the Arc operon.
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INTRODUCTION
The ability of a pathogen to control the spatio-temporal expression of virulence
genes required for pathogenesis requires the accurate sensing of the environment in
which it is found. Often many pathogens will coordinate the expression of virulence
genes with metabolism, by linking the regulation of these factors to known metabolic
regulators (19, 30). Investigation into the regulation of metabolic pathways activated
during an infection can thus provide insight into identification of the environmental and
cellular signals being sensed by the bacteria. Additionally, examination of the
transcriptional regulators involved in regulating the metabolic operon can reveal the
novel coordination of virulence factor expression with metabolism. A challenge then
becomes identifying the mechanism of regulation and delineating the contribution of
multiple regulators on a gene’s expression.
In the Gram positive pathogen Streptococcus pyogenes (group A streptococcus),
adaptation to the environment often involves the coordination of virulence gene
expression with the bacteria’s metabolism (27, 29). S. pyogenes is the known causative
agent of a wide variety of diseases including common superficial infection of the throat
and skin (pharyngitis and impetigo) as well as more invasive infections of soft tissue and
fascia (cellulitis and necrotizing fasciitis) (7). In S. pyogenes, linking the expression of
virulence genes to the metabolic state of the cell allows for the bacterium to quickly adapt
to changes in the environment. This adaptation requires not only changes in expression
of virulence factors, but also changes in metabolic pathways necessary for the production
of cellular energy. Recent identification of the role of the Arc operon and the utilization
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of arginine during an infection suggests that arginine catabolism, and the regulation of
this operon is necessary to efficiently colonize and infect a host.
Arginine catabolism in S. pyogenes occurs through the arginine deiminase
pathway encoded by the Arc operon (Figure 1), and aids to bacterial survival through
both the production of ATP and protection from acid stress (1, 9) (Figure 1). This
pathway involves utilization of three key enzymes: ArcA, ArcB, and ArcC along with the
antiporter, ArcD (2, 3, 8, 11, 14, 15, 24, 31, 32) (Figure 1). In addition to these proteins
the Arc operon is also found to encode a putative dipeptidase, ArcT, and a small protein
with homology to the GNAT family of acetyl transferases (17). Upstream of ArcA lies
an FNR/CRP-like transcriptional regulator, ArcR, which has been found to be essential
for activation of transcription in several Gram positive bacteria (25, 26, 33). Additionally
upstream of ArcR, transcribed in the opposite direction is the gene, ahrC.2, which
encodes a protein homologous to the arginine regulator ArgR found in Lactococcus lactis
and ArcR found in Streptococcus gordonii (11, 21). Research conducted in Streptococcus
gordonii has found activation of the Arc operon in response to arginine requires the
transcriptional regulator ArcR, which is homologous to AhrC.2 in S. pyogenes (11), while
activation of the Arc operon in response to oxygen availability requires the activator Flp
homologous to ArcR (10). Despite demonstrating the separate function these regulators
under these two conditions, analysis of both regulators influence on transcription in both
conditions have not been examined. This complex regulation of the Arc operon is
suggestive of its importance in bacterial growth and survival.
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In addition to the putative regulation by both AhrC.2 and ArcR, regulation of the
Arc operon in S. pyogenes has also been found to involve the two catabolite-sensing
regulators CcpA and LacD.1 (19, 20). CcpA, the major carbon regulator in S. pyogenes
is involved in prioritizing the utilization of metabolic substrates and has been found to
repress expression of arcA in the presence of glucose (20). Conversely, the regulator
LacD.1 has been found to activate the Arc operon during the exponential phase of growth
(20). In addition to controlling expression of the Arc operon both of these metabolic
regulators have also been found to regulate the expression of known virulence factors,
including the secreted cysteine protease SpeB (19, 20, 23).
The recent discovery of the contribution of arginine and citrulline catabolism to S.
pyogenes pathogenesis, suggests the requirement for the activation of the Arc operon
during an infection. Thus, inquiry into the in vitro regulation of this operon will provide
insight into the environmental signals being sensed by S. pyogenes that lead to the
activation of this operon. In order to initiate this investigation, in-frame deletions of the
two arginine-like regulators associated with the Arc operon were made. Analysis of these
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regulators influence on arginine catabolism demonstrated that both were required for
transcriptional activation of the Arc operon. Further experiments examining the ability of
the each regulator to bind to the region upstream of arcA revealed the binding of AhrC.2
occurred in an ArcR-dependent manner. Additionally, despite being both necessary for
the in vitro activation of the Arc operon, these two regulators produced varying
phenotypes in our mouse model of infection. Suggesting a complex but important role
for arginine regulation in the pathogenesis of S. pyogenes. Together this work will help
elucidate the manner in which the Arc operon is regulated in S. pyogenes, and further
help illuminate it’s ability to coordinate the expression of both metabolic and virulence
genes during an infection.
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RESULTS
Expression of the Arc operon requires both AhrC.2 and ArgR
To initiate investigation into the regulation of the Arc operon in S. pyogenes, inframe deletions in both ahrC.2 and arcR were generated. Initial attempts to assay for
arginine utilization involved
growth of both mutants in the
presence of 10 mM arginine.
Comparison to wild type
showed a noticeable difference
in final optical density (OD) in
the presence of arginine
indicative of a disruption in the
ADI pathway (Figure 2). To verify that this disruption was occurring on the
transcriptional level, the transcripts of several genes through out the Arc operon were
measured by real-time RT-PCR and compared to wild type. Transcript levels were
measured in both the exponential and stationary phase of growth for bacteria grown in Cmedium. C-medium is a complex medium rich in amino acids and peptides with a low
concentration of glucose. Previous research has found that growth in this medium results
in activation of the Arc operon, and thus would allow the function of both regulators to
be assayed.! Measurement of transcripts during exponential phase revealed that for both
mutants nearly all genes in the operon were down regulated between 60-90 fold (Figure
3). While in stationary phase the two mutants showed a down regulation of Arc genes
between 2-16 fold (Figure 3). Comparison of transcripts in wild type cells during
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exponential and stationary phase showed no significant shift in abundance during growth
(Figure 4), suggesting that the change in down regulation seen in the mutants was not due
to a shift in transcript abundance in wild type cells. Taken together this data suggests that
both ArcR and AhrC.2 are required for transcriptional activation of the Arc operon in Cmedium, and that additional growth phase dependent regulators may also influence the
transcription of the Arc operon.
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Binding of AhrC.2 to the promoter region of arcA is ArcR dependent
Previous investigation of the Arc operon in Enterococcus faecalis has revealed
that expression of the genes occur as a polycistronic mRNA with a single transcription
initiation start point upstream of arcA (3). To further investigate the mechanism of
regulation of the Arc operon, we next looked to observe the direct binding of ArcR and
AhrC.2 to the putative promoter region upstream of arcA using a previously described
biotinylated DNA pulldown assay (19). To monitor binding both ArcR and AhrC.2 were
modified with a C-terminal hemagglutinin (HA) tag and expressed ectopically from a
plasmid. To verify that both ArcR-HA and AhrC.2-HA were functional, the ability of
these constructs to complement the single mutants !ArcR and !AhrC.2, respectively,
were monitored by growth in arginine (data not shown). The relative increase in growth
of the complemented strains compared to the mutants in the presence of arginine,
suggested that the addition of the C-terminal HA tag did not disrupt the function of either

!

"#*!

protein. Initial analysis of binding to the arcA promoter revealed that under these
conditions AhrC.2-HA but not ArcR-HA was able to bind (Figure 5B). Binding of the
arcA promoter was found to be specific as demonstrated by the lack of binding to DNA
amplified from the upstream region of the arcR gene (data not shown).
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Previous research in Lactococcus lactis had demonstrated that AhrC.2 and ArcR
functioned as a complex (21). To investigate the influence of ArcR on the binding of
AhrC.2 to the arcA promoter, cellular extract of AhrC.2-HA expressed ectopically in
!ArcR was used in the DNA binding experiments. Surprisingly in the absence of ArcR,
the binding of AhrC.2 to the arcA promoter was nearly completely abolished. Together
this data suggests that under conditions tested AhrC.2 is able to bind to the DNA region
upstream of arcA in an ArcR dependent fashion.
!AhrC and !ArcR display different phenotypes in vivo
Given the complex regulation of the Arc operon and the recent identification of
the role of arginine catabolism in an S. pyogenes infection, we next wish to investigate
the influence deletion of these two
regulators may have in our
subcutaneous infection model.
Comparison of lesions formed in mice
infected with our wild type strain,
!ArcR, or !AhrC.2 revealed that
despite producing similar phenotypes
in vitro, deletion of ahrC.2 results in significantly smaller lesions compared to wild type,
while !ArcR does not (Figure 6). This surprising result raises many questions
concerning the additional role of these regulators in vivo and the mechanism by which
they regulate the Arc operon.
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DISCUSSION
In the present study we initiated investigation into the mechanism of regulation of
the Arc operon in S. pyogenes. Previous research has identified the Arc operon and
arginine catabolism is important for mediating bacterial survival during an infection, thus
suggesting an important role for regulation of this operon in vivo. Analysis of regulation
in vitro reveled that deletion of either arcR or ahrC.2 abolished activation of the Arc
operon, suggesting the requirement for both regulators for transcription. This requirement
was further supported by additional experiments that demonstrated the ArcR-dependent
interaction of AhrC.2 with the promoter region of arcA. However, analysis of these
mutants in vivo produced varying phenotypes, suggesting an alternative form of
regulation, or an additional function for these regulators during an S. pyogenes infection.
In bacteria, tight regulation of the ADI pathway is necessary to ensure arginine,
required for protein synthesis is not degraded unnecessarily. Previous research in low G
+ C bacteria have revealed the conservation of two transcriptional regulators clustered
near the Arc operon (34). Investigation in many of these low G + C bacteria have
revealed that transcription of the operon is dependent on one of these regulators (10, 26,
33). However, they have often failed to examine the function of the other additional
regulator associated with the Arc operon. In the present study the role of both regulators
associated with the Arc operon, and their involvement in the transcriptional regulation of
this operon were examined. In agreement with previously published research, deletion of
either one of the regulators homologous to ArcR or AhrC.2 resulted in disruption of
expression of the Arc operon (10, 26, 33). However, this work is the first to suggest the
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requirement for both ArcR and AhrC.2 for the activation of the Arc operon, and suggests
a more complex form of regulation previously envisioned.
While different, regulation of arginine metabolism in Lactococcus lactis reveals a
unique form of regulation similar to S. pyogenes. In L. lactis transcription of genes
involved in arginine catabolism and arginine biosynthesis are co-regulated to ensure
efficiency in arginine metabolism (22). This coordination is believed to occur through a
direct interaction between the homologs of AhrC.2 and ArcR, which is directly mediated
by arginine (21). In low levels of arginine AhrC.2 binds to the promoter of the Arc
operon preventing transcription. In the presence of increasing arginine, ArcR interacts
with AhrC.2 resulting in a decrease in affinity for the Arc operon promoter and an
increase in affinity for promoters regulating genes involved in arginine biosynthesis (21).
This change in affinity for promoters leads to the de-repression of the Arc operon and
repression of the arginine biosynthesis operon. Comparison of regulation of the Arc
operon in L. lactis to S. pyogenes found in contrast to requiring both regulators, only the
homolog of ArcR and not AhrC.2, is required for activation of this operon. This
difference in regulation may be partially explained by the lack of an arginine biosynthesis
operon in S. pyogenes, and thus the lack of requirement to coordinate expression with the
Arc operon. Nevertheless, the requirement for both regulators to repress the arginine
biosynthesis operon in L. lactis and their arginine-dependent interaction suggests these
regulators may have evolved to function as a complex.
As an initial attempt to investigate the interaction of these regulators with the
promoter of arcA we utilized a DNA pull down assay. This assay was efficient at
detecting a specific interaction between AhrC.2-HA and the DNA region upstream of the
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arcA promoter. Given the requirement for both regulators for the activation of
transcription, we had hypothesized that these proteins may function in a complex, with
both AhrC.2 and ArcR binding to the promoter simultaneously. However, despite
multiple attempts, we were unable to detect an interaction between ArcR-HA and this
DNA region. Despite this negative data, our previously stated hypothesis cannot be
completely ruled out. Indeed, a putative interaction between ArcR and AhrC.2 may
result in an increase in affinity for the arcA promoter, and that upon subsequent wash
steps this interaction between ArcR and AhrC.2 is disrupted. The decrease in binding of
AhrC.2-HA when expressed in a !ArcR background supports this model, suggesting the
requirement of both proteins for DNA binding. However, given that these interactions
were performed from crude extract, deletion of arcR may result in changes to the
concentration of another co-factor required for AhrC.2 binding. Further investigation
into this model with purified protein will be essential in elucidating the direct mechanism
of regulation, and the role that each regulator plays in activating transcription of the Arc
operon. Additionally, analysis of the DNA region upstream of arcA has revealed a weak
consensus with the previously identified binding sites of other arginine-like regulators.
Determination of the transcriptional start site of the Arc operon will aid in discovering the
exact DNA binding site of AhrC.2, as well as help identify additional genes regulated by
AhrC.2 and ArcR through promoter analysis.
The recent discovery of the role of arginine catabolism in the pathogenesis of S.
pyogenes suggested that regulation of this operon contributes to virulence. Given that
deletion of either regulator disrupted activation of this operon, we had hypothesized that
!ArcR and !AhrC.2 would phenocopy each other in our mouse model of infection.
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However, surprisingly deletion of arcR had no significant influence on virulence, while
deletion of ahrC.2 resulted in an attenuated strain with significantly smaller lesions
compared to both wild type and !ArcR. This variation in virulence raises many
interesting questions regarding the activation of the Arc operon in vivo and the possible
function of these regulators outside of the Arc operon. To further address these questions
will require identification of additional genes mis-regulated by deletion of arcR and
ahrC.2, as well as analysis of Arc transcription in vivo. Additionally, examination into
the influence of other regulators, including CcpA and LacD.1, as well as additional
environmental signals, including arginine, pH, and glucose, will allow for insight into the
activation of this operon both in vitro and in vivo. Coupled with in vivo data, these
experiments can provide insight into the environmental signals being sense by this
bacterium and the influence of these regulators on virulence in S. pyogenes.
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MATERIALS AND METHODS
E. coli strains, media, and growth conditions. Common molecular cloning techniques
utilized the E. coli strain DH5", which was cultured in Luria-Bertani medium at 37ºC
When appropriate antibiotics were added to the medium at the following concentrations:
kanamycin 50 µg/mL and erythromycin 750 µg/mL.
!
Streptococcus pyogenes strains, media, and growth conditions. Streptococcus
pyogenes HSC5(16) and mutant derivatives of this strain (Table 1) were utilized for these
experiments. Regular growth of strains was in Todd-Hewitt Broth (THYB) (DIFCO)
supplemented with 0.2% Yeast Extract (DIFO) unless indicated in the text. Specific
experiments utilized growth in C-medium (0.5% Protease Peptone #3 (DIFCO), 1.5%
Yeast Extract (DIFCO), 10 mM K2HPO4, 0.4 mM MgSO4, 17 mM NaCl).
Supplementation of medium with arginine or citrulline occurred after autoclaving
medium and was prepared by adding from a 0.5 M filter sterilized stock to a final
concentration of 10 mM. Streptococci grown on THYB medium solidified by the
addition of 1.4% Bacto Agar (DIFCO) were cultured anaerobically in sealed jars in the
presence of commercially available gas-generating packets (GasPak cat. #70304, BBL).
When appropriate antibiotics were added to the medium at the following concentrations:
chloramphenicol 3 µg/mL and erythromycin 1 µg/mL.

Construction of deletion mutants. All references to genomic loci are based upon the
genome of S. pyogenes SF370 (12). In-frame deletion mutations in genes encoding ArcR
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(SPy_1548), AhrC (SPy_1549), (SPy_1496), and ArcD (Spy_2150) were generated using
allelic replacement as previously described (28). Allelic replacement vectors were
constructed with the vector pJRS233 (13) either ,-./01-!2!3./4566!/7!/85.923!5:,5;6</;!
=>?!@")A!/.!BC!,-.55DE2C!9<12,</;!2;F!&G!3-/63-/.C92,5F!3.<H5.6!26 listed in Table 2.
All deletions were confirmed by PCR.

Isolation of RNA and real-time RT-PCR. As previously described(4) total RNA was
isolated from strains grown in the media and at specific times in the growth cycle as
indicated in the text. RNA was subjected to reverse transcription using iScript (Bio-Rad)
per the manufacturer’s instructions. Real-time RT-PCR analysis of cDNA samples was
performed using iQ SYBR green Supermix along with primers listed in Table 2. Relative
transcripts levels were determined using the !!Ct method with the recA transcript as a
standard as previously described (4).

Biotinylated DNA pulldowns. A biotinylated DNA pulldown assay was utilized as
described previously (19). Briefly, DNA regions of interest were amplified from
genomic DNA using 5’ biotinylated primers listed in Table 2 followed by purification of
the reaction using QIAquick PCR purification kit (Qiagen). Next 2 µg of the PCR
reaction was bound to the strepavidin-coated magnetic beads and washed to remove
unbound DNA. S. pyogenes cellular lysate of the specified strain was prepared and the
total protein concentration measured using a bichinchoninic acid assay (Pierce/ThermoFisher). For the pulldown, 2 mg of total cellular lysate from the specified strain was
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added to the DNA-coated beads, and incubated in 1 mL of binding buffer (10 mM TrisHCl [pH 8], 100 mM KCl, 3 mM MgCl2, 20 mM EDTA, 5 % glycerol, 40 µg/mL sheared
salmon sperm DNA [Invitrogen], and 10 µg/mL bovine serum albumin [Sigma]) at room
temperature. Following a 30-min incubation the beads were collected with a magnetic
particle separator (Invitrogen cat # K1585) and washed four times with 500 µL of
binding buffer. Protein was eluted by addition of 1 X protein sodium dodecyl sulfate
(SDS) sample buffer (1X; 50 mM Tris-HCl[pH 6.8], 100 mM dithiothreitol, 2% [wt/vol]
SDS, 0.1 % [wt/vol] bromophenol blue, 10 % glycerol) followed by boiling of the sample
for 5 mins. The magnetic beads were then removed with magnetic particle separator, and
the resulting sample was subjected to electrophoresis using 12% SDS-polyacrylamide
gel. The proteins were then transferred to a PVDF membrane for western blotting with a
rabbit polycolonal "HA antibody (1:10,000 final dilution) and peroxidase conjugated
goat "rabbit secondary antibody (1:10,000 final dilution; both from Sigma).

Subcutaneous infection of mice. As described previously infection of 6 to 8-week old
female SKH1 (Charles Rive Labs) mice were infected subcutaneously with 107 bacterial
CFUs of each indicated strain (5, 6). Following infection the resulting ulcers were
imaged on the day noted in the text, and analyzed using the image software ImageJ
(http://rsb.info.nih.gov/ij/index.html) to determine the area of the border of each lesion.
Differences in lesion area were tested for significance using the Mann-Whitney U-test.
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CHAPTER V
Conclusions and Future Directions

CONCLUSIONS
For many pathogens, the acquisition of nutrients is the main driving force in
virulence gene expression. Several virulence factors function through the delivery of
important nutrients required for bacterial growth. Thus it is not surprising that for many
pathogens changes in virulence gene expression and metabolism occur in a coordinated
fashion. In Streptococcus pyogenes, this coordination is achieved by co-opting metabolic
regulators for the expression of virulence genes. Previously, the catabolite-sensing
regulator LacD.1 has been shown to function as both a regulator of virulence and
metabolic genes, suggesting a unique confluence of metabolism and virulence gene
expression. In this work, examination of LacD.1’s function in S. pyogenes has provided
insight into the adaptation of LacD.1 into a novel regulator, as well as revealed the
importance of LacD.1 regulation in S. pyogenes fitness. Investigation of the LacD.1
regulon has identified the novel contribution of both arginine and citrulline metabolism to
pathogenesis, and its modulation of the host innate immune response. The major
conclusions of this work include: 1.) multiple residues dispersed throughout LacD.1 are
required for its regulatory function, 2.) the adaptation of LacD.1 as a regulator results in a
decrease in its ancestral enzymatic activity, 3.) the regulatory function of LacD.1 is
required for S. pyogenes fitness, 4.) the arginine deiminase pathway contributes to S.
pyogenes virulence through the catabolism of both arginine and citrulline, 5.) depletion of
arginine from extracellular milieu by S. pyogenes results in an inhibition of iNOS
activity, and thus NO production, 6.) Activation of the Arc operon requires both ArcR
and AhrC.2, and 7.) AhrC.2 can directly interact with the DNA region upstream of arcA.
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These studies reveal a unique coordination of virulence gene expression and
metabolism by the regulator LacD.1 and demonstrate the direct influence of bacterial
metabolism on pathogenesis. Upon infection, S. pyogenes encounters an environment
void of easily metabolized carbohydrates. Through both de-repression via CcpA and
activation via LacD.1, S. pyogenes is able to up-regulate alternative metabolic pathways
involved in utilization of complex carbohydrates, as well as express catabolic pathways,
such as the ADI pathway. The catabolism of arginine and citrulline by the bacteria
results in the production of ATP and ammonia, which can buffer against the acidic,
fermentation products created by the bacteria. In addition, depletion of arginine can
serve to prevent the host from utilizing this amino acid crucial for the production of NO,
a potent antimicrobial. During this shift in bacterial metabolism, LacD.1 regulation also
results in the de-repression of speB resulting in expression and secretion of this potent
protease. Upon secretion, SpeB can function to liberate peptides and arginine that can
continue to supplement the ADI pathway. Ultimately, this co-regulation of both arginine
catabolism and speB expression contributes to the fitness of S. pyogenes and
demonstrates an example of how pathogens have evolved to coordinate the expression of
virulence factors with metabolism.
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FUTURE DIRECTIONS
The coordination of metabolism and virulence gene expression is becoming more
and more evident in a number of pathogenic bacteria. Continuing to understand the
influence bacterial metabolism has on both the regulation of virulence factors and the
host response to a pathogen will be essential in furthering our understanding of hostpathogen interactions. The following discussion describes areas of research that will help
to solidify our current understanding of S. pyogenes pathogenesis.
Examine the mechanism of LacD.1 regulation and its coordination of speB and the
Arc operon.
Research examining the evolution of LacD.1 has revealed key residues necessary
for LacD.1’s regulatory function. Identification of these distinct regions suggests their
possible role in protein-protein interactions. Previous attempts to detect these
interactions have proven difficult, likely due to their short-lived lifetime along with
fluctuations in important metabolites that mediate these interactions. To address these
issues may involve the use of cross-linking agents to stabilize any putative interactions
with protein or DNA. Given the recent characterization of several chimeric enzymes
with altered ability to regulate, addition of these proteins in this analysis will allow for
the identification of novel interactions relevant to LacD.1’s regulatory function.
Previous studies have established LacD.1’s role in the repression of speB along
with the activation of the metabolic Arc operon (2, 6). However, examination of this
regulation has occurred under different conditions and different phases of growth. A
more in depth examination of LacD.1’s role in regulating the Arc operon will be helpful

!

"#&!

in understanding how environmental signals may influence both the expression of speB
and the Arc operon. Given the role of arginine catabolism in protection against acid
stress and the induction of speB transcription by an acidic pH (5), the coordination of
expression of these two pathways may suggest a functional interaction. Indeed, it would
be interesting to examine if the activation of the Arc operon via LacD.1 is increased by a
decrease in medium pH. This increase in activation would suggest protection from acid
stress via arginine catabolism might be supplemented by SpeB’s protease activity.
Further experimentation utilizing the established acid stress model would also allow us to
determine if SpeB activity is able to protect S. pyogenes via the ADI pathway, revealing a
unique contribution of SpeB activity to S. pyogenes’ metabolism.
Examine the influence of arginine catabolism on virulence.
The recent identification of arginine catabolism’s role in S. pyogenes pathogenesis
raises many interesting questions regarding its exact contribution to virulence. Given that
this pathway aids to bacterial metabolism with both the production of ATP and protection
from acid stress occurring simultaneously, it is difficult to determine which is necessary
in vivo. Preliminary evidence looking at the contribution of serine catabolism to S.
pyogenes pathogenesis has revealed evidence suggesting that arginine and citrulline
catabolism primarily contributes to protection against acid stress. Serine catabolism
funnels through pyruvate metabolism with the conversion of serine to pyruvate. Due to
this route of metabolism, supplementation of C-medium with serine results in a decrease
in the medium’s pH. Deletion of the two enzymes, SdhA and SdhB, responsible for this
catabolism results in an inability to utilize serine, as well as attenuation in virulence
(Figure 1). However, deletion of both arcB and sdhA/B does not result in further
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attenuation compared to the single mutation (Figure 1). This phenotype may suggest that
preventing the catabolism of serine diminishes fermentation, and thus the requirement for
arginine catabolism to protect against acid stress. Further investigation into the pH of a
lesion formed by both wild type S. pyogenes and a !ArcB during an infection will be
essential in understanding both the contribution of arginine/citrulline catabolism to acid
protection, as well as the reveal the environmental pH encountered by S. pyogenes.
Additionally, monitoring changes in pH through out an infection may reveal a novel
correlation with the temporal expression of S. pyogenes virulence factors.
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Identify the citrulline transporter in S. pyogenes, and the role of ATP production in
protection against acid stress.
The recent discovery of the utilization of citrulline during an infection raises
many interesting questions regarding its transport into the cell, and its influence on gene
expression. Identification of the transporter involved in bringing citrulline into the cell
will be essential in dissecting the exact contribution of citrulline catabolism in virulence.
Additionally, examination of the role of arginine catabolism in protection against acid
stress has raised many questions regarding the exact contribution of the production of
ATP versus the production of ammonia in protecting bacteria. Further examination of the
intracellular pH in the presence of arginine in both wild type and the arc mutants will
provide insight into the exact mechanism of protection. While difficult, advances in pHresponsive flurophores may allow for monitoring of the intracellular pH in real time.
Influence of arginine sensing on the expression of the Arc operon and virulence
genes in S. pyogenes
The recent discovery of the role of arginine catabolism in an S. pyogenes
infection, suggests that activation of the Arc operon by AhrC.2 and perhaps ArcR is
important for pathogenesis. Examination of the genome of S. pyogenes reveals the
presence of two additional arginine-like regulators (SPy_1496 and SPy_2150).
Preliminary studies have revealed that deletion of these additional regulators do not
disrupt the utilization of arginine (data not shown), suggesting their regulatory function
lies elsewhere. Given the utilization of arginine during an infection it will be interesting
to examine if the presence of this amino acid triggers expression of additional metabolic
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pathways or virulence genes via an arginine-responsive regulator. Indeed, in many
pathogens including Legionella pneumonphila, Staphylococcus aureus, and
Streptococcus pneumoniae regulators of arginine metabolism have been found to include
regulation of several virulence factors (1, 4, 7). Investigation in to the genes misregulated in the four mutants (!ArcR, !AhrC.2, !SPy_1496, and !SPy_2150) in the
absence and presence of arginine will provide insight into the influence arginine sensing
has on gene expression in S. pyogenes.
Examine influence of arginine/citrulline catabolism on host response.
The inhibition of iNOS activity during an infection through arginine depletion
reveals a unique influence of S. pyogenes’ metabolism on the host innate immune
response similar to the influence of RocF in Heliobacter pylori. Further experiments
looking at the effect of the arginase, RocF on gastric epithelial cells have shown a clear
influence on cytokine expression and host signaling (3). Given this similar modulation of
iNOS activity, it will be interesting to explore the influence of arginine catabolism on the
host response further, by examining cytokine expression during an infection, and
exploring possible changes to the activation profile of macrophages.
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